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Introduction and Literature Review
As we witness cells mingling through themicroscope, we
are challenged to understand howthese tiny units of life
communicate.Through genetics, we have begun to map the
intricate journey of the cell cycle that is traversed bycells
during their replication.The regulation of the cell cycle
has been elaborately described (Hartwell andWeinert, 1989;
Murray and Kirshner,1989; Nurse,1990), and this process
involves both an intrinsic genetic programming and essential
extrinsic factors that govern cells making up the organism.
Growth regulatorsarecuesforintercommunication;they
coordinatecellgrowth and activitiesduringembryonic
development and throughout life.
Cells grown in culture have similar growth requirements as
cells growing in vivo (Sato, 1979).Nutrients provide fuel
for the cell.Growth regulators control cell growth and
differentiation. A substratum is often required for the cells
to grow; some examples of cell adhesive proteinsinclude
fibronectin, laminin, and collagen. Cell attachment proteins
anchor cells to allow internal organization and topermit
cell-cell interactions.2
Cells have been traditionally derived and culturedin the
presence of serum, but serum is acomplex substance.There is
often variability in the components that make up serum.This
makes for problems in reproducibility when serumis used in
experiments.Serum contains a mix of peptide growth factors
and hormones that may interfere withdetermining specific
growth regulator's effects on cell activities(Temin et al.,
1972; Brooks, 1975).Also, there are growth inhibitors in
serum that interfere with cellgrowth (Rawson et al., 1991).
Mouse embryo cells derived andmaintained in vitro in
serum-supplemented media will at first go through a numberof
celldivisionsandthen enteragrowth crisis. Only
genomically altered cells will continue to grow; those that
are tetraploid or heteroploid, andwith severe chromosomal
aberrations.The normal karyotype of the cells will be lost.
Swiss, BALB and NIH lines (3T3, 3T6, 3T12) as well asC3H
10T1/2, which are commonly used in studies ofcarcinogenesis
and growth control, are all derived this way, andall exhibit
major chromosomal abnormalities.However, mouse embryo cells
derived in a defined, serum-free media remainkaryotypically
normal and do not undergo a growth crisis (Loo et al.,1987).
Serum-free cells have been used to study specificgrowth
factor's effects on their activities.
Serum-free cell culture allows us to define and selective
manipulate of the cells' environment.Although serum-free
cellcultureremainsalargely empiricalscience,some3
guidelines for growing various types of cells have emerged
(Barnes and Sato, 1980a).Cells in vivo are exposed to a
complex array of nutrients, growth factors and extracellular
matrices.If the cell is to survive in culture, the medium
must provide an adequent environment. Serum-free media
contains all the essential ingredients that cells require.
Besides the proper balance of salts, buffers and amino acids,
all cells require hormones and growth factors.For example,
insulin is required by most cells for survival in serum-free
medium.The concentration of insulin required by serum-free
cells is often much higher than physiological levels.This
suggests that insulin at these higher concentrations maymimic
the effects of other growth factors.
Binding proteins, including transferrin and albumin, are
also required by most cells and may serve to provide essential
nutrients and minerals and to bind up and remove toxins.An
essential growth factor for the survival of many ectodermal
and neuroectodermal cell types is epidermal growth factor
(EGF);EGF stimulates the proliferation of many cells and is
requiredbymostnormalcellsgrowinginculture.
Interestingly, often the transformation of cells obviates the
need for specific growth factors, like EGF.For example,
mouse serum-free derived cells (SFME) whentransformed by ras
oncogenes lose the requirement for EGF(Shirahata et al.,
1990).
Most cells require a substratum, and this can be provided4
using specific attachment factors, such as fibronectin, cold-
insoluble globulin or serum spreading factor.The use of the
polymer,polylysine,canalsopromotecellattachment,
presumably by its highly positive charge.
Peptide growth factors are growth regulators that bind to
cell surface receptors and stimulate cell proliferationand/or
differentiation (Deuel, 1987, Cross and Dexter, 1991).They
regulate a variety of responses in the cell.There is a
multitude of signaling pathways to the nucleus thatvaries
between growth factors, and the same growth factor maysignal
many different pathways in the samecell.All peptide growth
factors are known to have their own cell surface receptor.
Commonly, the receptor responses to binding of the growth
factor by signaling a tyrosine kinase activity; the EGF, PDGF
and CSF receptors are tyrosine kinases (Yarden andUllrich,
1988).Growth factors also activate other kinases, including
protein kinase C, and G proteins.
Many oncogenes are related to growth factors or growth
factor receptors (Varmus, 1987); for example the sis oncogene
shares homology with platelet-derived growth factor, the erbB
and neu oncogenes are related to the EGF receptor.Much
research has focused on growth factors'control of cell
growth, and how oncogenes abrogate this control (Cantley et
al., 1991).The finely regulated communications by peptide
growth factors can be disrupted at several points.Tyrosine5
kinase activity of the growth factor receptor can bealtered,
creating a continuous and unregulated cell signaling event.
Alterations in protein kinases (e.g. RAF), phosphorylasesand
phosphatasesalsomayjeopardizeinternalorderand
communication with outside the cell.The checkpoints that
regulate the cell cycle events of normal cells may belost in
transformed cells.
Serum-free mouse embryos cells (SFME) transformedwith the
Ha-ras, N-ras and neu oncogenes are capable ofgrowing in the
absence of epidermal growth factor, which is essentialfor the
growth of untransformed SFME (Shirahata et al., 1990; Rawson
et al.,1990a).Serum free mouse embryo cells have been used
in our laboratory to identify new oncogenes, taking advantage
of this unique property of the cell line.
Serum Free Derived Mouse Embryo Cells
The cell-line, known as serum-free mouse embryo cells
(SFME), was isolated from a sixteen day old Balb/c mouse
embryo, and has been continuously passaged in serum free
medium without loss of its normal karyotype (Loo et al.,
1987).These cells have a doubling time of approximately 20
hours, and a fibroblast-like morphology that changeswith the
culture conditions.For instance, in the presence of TGF p,
SFME become elongated (Fig. 1.1), and sticktightly to the
tissue culture flask, presumably do to the increased synthesis6
of extracellular matrix proteins. The recipe used for
growing SFME is a 1:1 mixture of Ham's F12 /DMEM medium in the
presence of insulin, transferrin, epidermal growthfactor,
high density lipoprotein (HDL), and selenium in a fibronectin
precoated flask to provide cell attachment (Loo et al., 1989).
ThecellsrequirebothinsulinandEGFforgrowth.
Transferrin provides iron and may regulate other responses,
selenium serves as an antioxidant, HDL provides the cells with
essential lipids, and fibronectin promotes cell attachment.
After 20 hours of EGF removal,the cells will enter a
programmed cell death, which is irreversible but can be halted
by inhibitors of protein synthesis and transcription (Rawson
et al., 1990).Serum-free mouse embryo cells are reversibly
growth-inhibited in the presence of 10% fetal calf serum
(Rawson et al., 1991).Recently it was determined (Sakai et
al., 1990) that in the presence of transforming growth factor
p (TGF (3) or 10% calf serum, SFME will express the astrocyte-
specificdifferentiation markerfilialfibrillaryacidic
protein (GFAP). This is an intermediate filament found only in
matureastrocytes. TheexpressionofGFAPbySFME
demonstrates the differentiation-promoting effects of TGF p on
these astroblast precursors. Interestingly, the effects are
reversible upon removal of the growth factor. A major part of
this thesis will discuss TGF p induction and regulation of
specific genes in SFME.7
Astrocytes and the Brain
Astrocytes are a type of glial cell.They are the most
abundant cells found in the brain, and are noted for their
stellate appearance (Fedoroff and Vernadakis, 1986). They are
distinguishedfromothercellsbytheircell-specific
expression of a 49,000 M.W.intermediate filament, glial
fibrillary acidic protein.Astrocytes provide many functions
in the brain.They are responsible for the regulation of the
brain'sextracellularenvironment, andmonitor the
concentrationsofexcitatoryionsandneurotransmitters
released by neurons into the extracellular space.Astrocytes
provide nutrients and growth factors for neurons and glial
cells.Some types of astrocytes regulate what passes into the
brain at the blood brain barrier.There, they form a close
junction with endothelial cells lining the capillaries.
There are many types of astrocytes; the radial glial
cells are a type of astrocyte that provide a scaffold for the
migration of neurons and other brain cells from their site of
origininthe developing neuroectoderm,totheirfinal
destination in the mature central nervous system.Some
astrocytes are phagocytes and can remove the debris from
degenerated neuronsand from inflammatory activitiesof
microglia.Astrocytes are immunocompetent cells, and can
phagocytoseand expressforeign antigensandthe major
histocompatibility class II antigen at their surface.They
release cytokines, like the interleukins, which stimulates the8
activities of T helper cells that migrate into the brain.
Some astrocytes can depolarize and may be the recipient of
"synaptic" neuronal transmissions, although the consequences,
if any, are not yet understood (Muller et al., 1992).
The brain is an intricate web of network; spun into its
pathways lies the primal program of instinct interwoven with
the powers of creativity and imagination. Many other cells in
the brain besides neurons coordinate activities(Ramon y
Cajal,1909), these include the astrocytes, the microglia
which are phagocytic cells, the oligodendrocytes that insulate
the neuronal axons and ependymal cells.
The development of glial cells has been closely examined
in vivo and in vitro, and in each case the progression towards
glial differentiation is the same (Lillien and Raff, 1990).
Theneuroectodermgivesrisetotheneuroblastsand
glioblasts.The neuroblast proceeds the glioblast in its
maturation.The first type of glial cell to appear is the
type I astrocyte, detected by its expression of GFAP in mouse
embryos at day 16.The oligodendrocytes are next to appear,
typicallyduringthefirstday postnatally. TypeII
astrocytes arise from the same cell precursor, and will be
next to differentiate at the beginning of the second week
following birth.The direction of oligodendrocyte-astrocyte
(0-2A) progenitor cells differentiation has been elaborately
examined using the rat optic nerve as a model system for CNS
glial cell development (Raff et al., 1983, Raff, 1989).It9
appears that the type I astrocytes providesignals, including
the release ofa23,000M.W.protein known asciliary
neurotrophic factor, that stimulate differentiation of the 0-
2A progenitor cells .Ciliary neurotrophic factor and other
filialcellregulatorymoleculesassociatedwiththe
extracellular matrix are believed to mediate their effects on
0-2A progenitor differentiation simultaneously.
The extracellular matrix can influence the behavior of
vertebrate neural cells by promoting their adhesion and
neuriteoutgrowth(Neugebaueretal.,1988). Neurite
outgrowth requires calcium dependent cell adhesion molecules
andtheintegrinextracellular matrixreceptors. The
integrins will bind to specific cell attachment proteins,
including fibronectin, vitronectin and laminin (Rauvala et
al., 1989). Laminin, which is the most effective of the
extracellular matrix proteins in promoting neurite outgrowth
of retinal neurons, is expressed on the surface of cultured
astrocytes. Vitronectin and it's aV 03 integrin receptor have
recently been detected in the brains of Alzheimer's victims
(Akiyama et al., 1991).Proteases and protease inhibitors are
alsoinvolvedin neuriteoutgrowth,and may befinely
regulated by localized glia to coax the growth of neurons
during development and regeneration. Some proteases and
protease inhibitors that are known neurite-regulating proteins
include protease nexins, thrombin and plasminogen activator
(Knauer and Cunningham, 1984).Interestingly, the cell-10
secreted glia-derived protease inhibitor nexin complexed with
thrombin have been found to specifically interact with the
cell adhesion molecule, vitronectin (Rovelli et al., 1990).
S-Protein: Alias serum-spreading factor, vitronectin
S-protein is a 75,000 M.W. serum glycoprotein produced at
high concentrations by the liver.It has also been detected
in the brain (Akiyama et al., 1991).This protein has many
functions; it is involved in blood coagulation and will bind
and protect thrombin from inactivation by antithrombin III
(Podack et al., 1986). S-protein is also known as serum
spreading factor,and was purified from serum as a cell
attachment factor in culture (Barnes et al., 1980b).It is
also known as vitronectin since it can bind to glass (Hayman
et al., 1983).S-protein can bind other proteins including
the nexins(Rovelli et al.,1990), plasminogen activator
inhibitor(Declercketal.,1988),and membersofthe
complement family, the cascade of cell lysis proteins (Podack
et al., 1977).When bound to nascent complement components,
it may protect bystander cells. Recentlyithas been
determined that TGF 13 will enhance the expression of S-protein
in human HepG2 hepatoma cells (Koli et al., 1991).TGF 13 also
regulates the expression of other cell attachment proteins and
their receptors,including fibronectin,collagen, and the
integrins.One of integrin receptors binds S-protein at an
arg-gly-asp sequence at the amino terminal region of the11
protein (Jenne and Stanley, 1985).
The ability of S-protein to bind filial- derivednexin-
thrombin complex may potentiate the neurite-promoting activity
of the serine protease inhibitor (Rovelli et al., 1990).S-
protein and its receptor have also been detected in thebrains
of Alzheimer's victims,possibly indicating inflammatory
responses within these diseased brains (Akiyama etal., 1991).
The neurodegenerative disease, Alzheimer's disease affects
seniors, typically over the age of 65 years (Yamaguchi et al.,
1988).This disease is characterized by diffuse plaques and
internal neurotangles found associated is the marker protein
$3 amyloid.p amyloid deposits are due to aberrations in the
processing of its precursor, amyloid precursor protein (APP).
The exact function of the precursor is not fully known
(Selkoe, 1990).Some possibilities include a role in blood
hemostasis, cell attachment, and gene activation (Deryk Loo,
personal communication). Two of the three alternatively
splicedtranscriptscontain theKunitzserineprotease
inhibitor.13 amyloid is toxic to neurons and other cells at
high concentrations (Yankner et al., 1989; Yankner et al.,
1990)anditpossiblyisgrowthstimulatoryatlow
concentrations.Both neurons and filial cells (Frederickson,
1992) may be involved in the deposition of the p amyloid
plaques and tangles.Genetic linkage analysis has found that
the autosomal dominant condition known as hereditary cerebral
hemorrhage with amyloidosis Dutch type (HCHWA-D) shows a12
single point mutation in the p amyloid protein (Levy etal.,
1990).Similarily, the Icelandic version of HCHWA has a
single base point mutation in the gene coding forcystatin C
(Cohen et al.,1983; Grubb et al.,1984).These genetic
aberrations are believed to be primarily responsible forthe
onset of these diseases.Victims of HCHWA-I typically begin
showing symptoms, including cerebral hemorrhage andcerebral
amyloid deposits, in their fifth decade of life.
Prologue to the Cystatin C Research
We have found that TGF p strongly induces theprotease
inhibitor cystatin C in proastroblasts, as well asinducing
their differentiation into astroblaststhatexpressthe
developmental marker filial fibrillary acidic protein.The
induction of cystatin C in vivo may be both a developmental
and an inflammatory response in the brain.It may be involved
in the regulation of peptide neuromodulators releasedinto the
extracellular space in the brain.
Cystatin C is a secreted cysteine protease inhibitor of
the family of proteases that include papain, and thecathepsins
B, H, and L (Rawlings and Barrett, 1990).The cathepsins are
lysosomalproteases,and cathepsinsBand D have been
associated with amyloiddepositsinAlzheimer'sbrains
(Cataldo and Nixon,1990).Cystatin C is a competitive
inhibitor of these proteases, with a Ki value ranging between
10-7 and 10-11M.Cystatin is produced by many types of cells13
and tissues, and is found at high concentrationsin body
fluids, including serum, semen, urine, and the cerebral spinal
fluid of the central nervous system (Abrahamson et al., 1990).
Therearethreeclassesofcysteineproteinase
inhibitors.Class I and II are low molecular weight compounds
(approx. 12,000 to 17,000 M.W.) and account for most ofthe
cysteine protease inhibitory activity found in the body.Some
of these include the cystatins A, 8, C, and S and thestefins.
Type III protease inhibitors include the kininogens,high
molecular weight proteins (approx. 78,000 M.W.) thatcontain
three cysteine protease inhibitory domains and the sequence
for bradykinin at their carboxyl termini.The kininogens are
found predominantly in the blood, functioning as both protease
inhibitors and as regulators of inflammation. Interestingly,
they are induced during aging (Sierra et al., 1989).
Thus far,cystatin C cDNA has been cloned in human
(Abrahamson et al., 1987), rat (Cole et al., 1989) and mouse
(Solem et al., 1990).All contain an amino terminal signal
sequence between 17-23 amino acids inlength; the mature
protein consists of 12 amino acids.There are two disulfide
bonds and a' putative asparagine-linked glycosylationsite.
Cystatin C has been found to be growth stimulatory for 3T3
mouse fibroblasts (Sun, 1989), and also forcertain kidney
cells (Tavera et al., 1992).It is a major secretory product
of human alveolar macrophages (Chapman et al., 199).In these
cells, it is down regulated during activation responses14
and is reduced in the macrophages of smokers.Cystatin C is
produced to high concentration by the choriod plexus of the
brain, the region responsible for the bulk of the cerebral
spinal fluid.Cystatin C is produced by astrocytes (Zucker-
Franklin et al., 1987).This secreted protein is strikingly
found associated with the filaments and bundles of fibrils in
the cytoplasm and nucleus.The presence of cystatin C gives
evidence that astrocytes have some properties of monocytes,
possibly they play a role in the development of some forms of
amyloidosis.There may be a developmentally-related
expression of cystatin C, since astrocyte precursors do not
express the gene at comparable levels (Solem et al., 1990).
Cystatin C expression has been studied in the developing brain
and compared with the expression of transthyretin and the 0
protein 0 amyloid).It is detected at low levels in the
embryo, and reaches its highest concentration directly after
birth, remaining at this level throughout adulthood. It's
increased presence has been correlated with the development of
the choriod plexus (Thomas et al., 1989).
The gene for the human cystatin C has been cloned and
sequenced (Abrahamson et al., 1990). Cystatin C gene contains
three exons and two introns that span 4 kilobases. The gene
is expressed in all tissues examined, including kidney, liver,
pancreas, intestines, stomach, antrum, lung and placenta. The
apparent non-tissue specific expression of the gene is
believed to be because it has housekeeping features in the15
regulatory 5' flanking region (i.e., lacks typical CHAT -box,
isnotablyGC-rich,andcontainsbindingsitesfor
transcription factor Spl).
Littleisknown abouttheregulation ofcystatin C
expression although itisa highly expressed and common
protein.Other class II cystatins are tissue-specific; an
exampleiscystatinSwhichismainlyfoundinthe
submandibularglandsandisinducedin responsetop-
adrenergic agonists such as isoproterenol (Shaw et al., 199).
In this thesis I will discuss what appears to be an mRNA
stability regulation of cystatin C in mouse astroblasts by the
peptide growth factor TGF p.
An Introduction to Transforming Growth Factor p
Transforming growth factor13plays multiple roles in cell
growth and differentiation of many types of cells (Massague,
1990). In particular, the development of mesodermal tissue
seems to be affected by the growth factor (Heine et al.,
1987).Recently, TGF p has been attributed to a variety of
responses in the brain, with astrocytes being predominantly
influenced (Saad et al., 1991; Wahl et al., 1991).
There are five known sub-types of TGF p (Rizzino, 1988).
The degree of homology ranges from 6496 (TGF pi vs TGF 134)to
82% (TGF 132 vs TGF po.TGF p, is a prototype; a disulfide-
linked dimer of two identical chains of 112 amino acids.TGF
13 is synthesized as the C-terminal domain of a 390 amino acid16
precursor.The receptor for TGF p is found on every cell
type, and does not contain a tyrosine kinase moiety like many
peptide growth factor
TGF p homologues
Mullerian inhibitory
that modulate gonadal
Biological activities
(Sporn et al., 1987).
receptors.
include the activins, inhibins and the
substance, all very important factors
activities and embryonic development.
of TGF p are diverse and cell-specific
TGF p regulates the proliferation of
many cells,including the growth arrest of certain lung
epithelial cells and keratinocytes.TGF p also exerts a
strongantiproliferativeactiononBlymphocytes,T
lymphocytes,andthymocytes. Themechanismofgrowth
inhibitionbyTGFpmayinvolvethesuppressionof
retinoblastoma protein phosphorylation.TGF p is a mitogen
for certain cell types, and it stimulates proliferation of
certain fibroblasts and osteoblasts.SFME cells do not show
a growth rate response to TGF 13.
TGF p induces the expression of many genes that are often
involved with the production of the extracellular matrix. TGF
p induces the genes for fibronectin and collagen in several
fibroblast cell lines.TGF p also regulates the expression of
vitronectin, proteoglycans, and other matrix proteins.The
receptors
by TGF 13.
proteases
for some of these matrix proteins are also regulated
TGF 13 regulates the synthesis of several different
and protease inhibitors that affect matrix stability
andturnover. TGF 13inducestheproteaseinhibitors17
plasminogen activator inhibitor, TIMP, and cystatin C and down
regulates the synthesis of collagenase, plasminogen activator
and transin/stromelysin. TGF13also modulates cell adhesion by
upregulating the synthesis of LFA-1, a cell-cell adhesion
receptor which binds to the intercellular adhesion molecule
ICAM-1 on the surface of lymphoid cells.
Transforming growth factor13promotes the differentiation
ofSFME cell proastroblasts,inducing the genefor the
astrocyte-specific differentiation marker filial fibrillary
acidic protein.TGF13also induces in astrocytes the genes
for nerve growth factor (Lindholm et al., 1990), NCAM and Ll
cell adhesion molecules (Saad et al., 1991) and cystatin C.
The regulation of certain genes induced by TGF13has been
explored (Massague, 1990).TGF13increases the mRNA for
collagen, fibronectin and thrombospondin both in the presence
and absence of mRNA stability changes, depending on cell
density (Penttinen et al.,1988).TGF 13suppresses c-myc
expression by inhibiting the initiation of transcription of
the gene.Inhibition of this growth related gene by TGF13
appears to be through its action on the retinoblastoma protein
(Laiho et al.,1990).In this report, we discuss mRNA
stability regulation of cystatin C by the growth factor.
mRNA Stability: a Level of Gene Regulation
There are many points where the expression of a gene can18
be controlled.Regulation of transcription is common, and
this can be coordinated at initiation, during elongation, or
at termination. Splicing and further processing of the
nuclear RNA may be regulated, as well as transport of the
mature nuclear mRNA from the nucleus.In the cytoplasm, mRNA
may be regulated by changes in stability. Events during
translation may determine the fate of a gene's expression.
Some examples of mRNA stability regulation will be discussed,
since we find regulation ofcystatin C mRNA stability by TGF
p in serum-free mouse embryo cells.
Messenger RNA decay is now recognized as a major control
point in the regulation of gene expression. (Brawerman, 1989)
Certain regions of the mRNA may influence its stability.
Often it is the 5' and 3' untranslated portions of the message
that are involved.Cellular factors (specific ribonucleases
or other cellular proteins) typically are associated with
regulation at these target regions.
The mRNAs encoding ferritin and transferrin have specific
sequences in their 5' and 3' untranslated regions (UTRs) that
form a stem-loop structure to which the iron responsive
element (IRE) interacts and is regulated by iron (MUllner et
al., 1989; Leibold and Munro, 1988).In the absence of iron,
IRE will interact with these loops,and in the case of
ferritin, translation will be blocked.IRE also binds to the
3' end of transferrin and stabilizes the mRNA.
The 3'-untranslated region of certain short-lived mRNAs,19
including c-myc,c-fos,and certain lymphokines contains
multiple copies of AII-rich motifs that are responsible for the
instability of these messages.Introducing several repeats of
the consensus sequence I:JAMMU to the 3'UTR of globin mRNA
dramatically reduces its stability (Shaw and Kamen, 1986).
Regions at both the 5' and 3' ends of several
mRNA are necessary for regulating stability (Ross
1986; Morris et al., 1986)A destabilization of
histones'
and gobs,
histones'
message takes place when DNA synthesis is complete after S
phase. Thereisalsoevidencethatthereispost-
transcriptional regulation of the primary transcript in the
nucleus.
A very profound effect on mRNA stability is seen in
regulation of the vitellogenin mRNA by estrogen (Blume et al.,
1987).In Xenopus liver, vitellogenin mRNA has a half life of
5 hours when estrogen is present, and 160 hours if estrogen is
removed from the culture medium.The 5' and 3'UTR of the
message seems to be required for this regulation (Nielsen
Shapiro, 1990).
In this thesis, I reportstudiesthat examine the
and
regulation of cystatin C mRNA stability by TGF p.We have
found that TGFpregulates the cytoplasmic stability of
cystatin C mRNA, and also I believe the primary transcript can
be detected in the total RNA of SFME grown in the presence of
TGF p.Although the detection of primary transcript RNA by
Northern blot analysis is not common, there are reports that20
clearly identify unprocessed RNA, particularly when genes are
strongly induced (Ferrari et al., 1992).(A)
(B)
21
Fig. 1.1:Morphology of SFME grown with and without TGF p.
(A) SFME grown under serum-free conditions (F12/DMEM medium
containing high density lipoprotein (10.ig/m1), insulin (10
µg /ml), transferrin (25 4g/m1), epidermal growth factor (50
ng/ml) in dishes precoated with fibronectin (10 µg /ml). (B)
TGF p(2 ng/ml) added to the plates for 24h.22
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SUMMARY
Human S-protein is a serum glycoprotein that binds and
inhibitstheactivatedcomplementcomplex,mediates
coagulation through interaction with antithrombin III and
plasminogen activator inhibitor I, and also functions as a
cell adhesion protein through interactions with extracellular
matrix and cell plasma membranes.A full length cDNA clone
for human S-protein was isolated from a lambda gt11 cDNA
library of mRNA from HepG2 hepatocellular carcinoma cell line
using mixed oligonucleotide sequences predicted from the
amino-terminal amino acid sequence of human S-protein.The
cDNA clone in lambda was subcloned into pUC18 for Southern and
Northern blot experiments.Hybridization with radiolabeled
human S-protein cDNA revealed a single copy gene encoding S-
protein in human and mouse genomic DNA.A 1.7 Kb mRNA for S-
protein was detected in RNA from human liver and from the
PLC/PRF5 human hepatoma cell line.No S-protein mRNA was
detected in mRNA from human lung, placenta, or leukocytes or
in total RNA from cultured human embryonal rhabdomyosarcoma
(RD cell line) or cultured human fibroblasts from embryonic
lung (IMR9 cell line) and neonatal foreskin.A 1.6 Kb mRNA
for S-protein was detected in mRNA from mouse liver and brain.
No S-protein MRNA was detected in mRNA from mouse skeletal
muscle, kidney, heart or testis.24
INTRODUCTION
Human S-protein is a serum glycoprotein that wasfirst
identified as an inhibitor of the formation of the complement
membrane attack complex, preventing complement-dependent cell
lysis (Podack et al., 1977, 1978; Podack and Muller- Eberhard,
1979). S-protein functions additionally in the terminal
stages of the coagulation system by binding andprotecting
thrombin from inactivation by antithrombin III (Podack et al.,
1986),and also binds heparin (Barnes et al.,1985)and
plasminogen activator inhibitor I(Declerck et al., 1988).
The protein exists in serum as a 75,000 molecular weight
molecule and a 65,000 molecular weight molecule that arises
from the 75,000 molecular weight form by proteolytic cleavage.
In addition thrombin-catalyzed cleavage of human S-protein
yields a single 57,000 molecular weight protein (Silnutzer et
al., 1984).
Determination of the base sequence for the gene encoding
human S-protein revealed that this protein was identical to a
cell adhesion molecule previously isolated independently in
several laboratories and termed spreading factor or epibolin
(Jenne and Stanley, 1985; Know et al., 1979; Barnes et al.,
1980b; Stenn et al., 1981; Barnes et al., 1983; Barnes and
Silnutzer, 1983; Fuquay et al., 1986).The name vitronectin
has been suggested for this protein (Hayman et al., 1983).25
Cell membrane receptors for the protein bind to an arg-gly-asp
sequence located at position 45-47 from the amino terminal of
S-protein (Suzuki et al., 1985).Previous work from Jenne and
Stanley (1987) indicates that human S-protein shares homology
and exon-intron arrangement with genes for hemopexin, transin
and interstitial collagenase.
Human S-protein is synthesized by liver in vivo and by
HepG2 human hepatoma cells in culture (Suzuki et al., 1983;
Jenne and Stanley, 1987; Barnes et al., 1985), and monoclonal
antibodies to human S-protein detect the molecule associated
with several cell types, including human platelets (Barnes et
al.,1983) and cultured human fibroblasts (Hayman et al.,
1983).The protein also has been reported to be present in
muscle, kidney, lung and placenta (Hayman et al., 1983).It
hasbeensuggestedthatS-protein may beproduced by
fibroblasticcells(Haymanetal.,1983),leadingto
deposition of the protein in multiple localizations in vivo.
However, we can detect the protein produced in vitro only in
cultures of liver-derived cells (Barnes et al., 1985).For
this reason we examined the pattern of synthesis of S-protein
mRNA in various tissues.In addition, we were interested in
the relative evolutionary conservation of the S-protein gene
in various species, because monoclonal and polyclonal antibody
to human S-protein recognized only the human and monkey
proteins (Barnes et al., 1983; Barnes et al., 1985),
suggesting possible unique features in this protein among26
primates.
In this paper we report the results of Northern blot
experimentsprobing humanandmousemRNAfromseveral
different types of cell lines and tissues.Although mRNA for
the protein was detected in liver and liver-derived cell
lines,no mRNA for the protein was detectedin cultured
fibroblasts or in RNA from kidney,placenta or muscle,
suggesting that the S-protein detected in these cases (Hayman
et al., 1985) originated from other sources.In addition, the
genomic DNA of human, mouse, dog, rat, monkey, rabbit and cow
were found to contain a single copy gene forS-protein in a
sufficiently related form to be detected by Southern blot
analysis.27
METHODS
Embryonal lung human fibroblast (IMR9), human embryonal
rhabdomyosarcoma (RD) and human hepatoma (PLC/PRF5) cell lines
were obtained from the American Type CultureCollection,
Rockville, Md.Human liver, lung, placental and leukocyte
MRNA and mouse liver, brain, skeletal muscle, heart, kidney
and testis MRNA and a nylon DNA blot containing 8 gg each of
human, monkey, mouse, rat, dog, cow, rabbit, chicken and yeast
genomicDNA digested withEcoRIwerepurchasedfrom
Clonetech, Palo Alto, Ca.A nylon DNA blot containing 8.0 gg
each of human placental genomic DNA or Balb/c mouse genomic
DNA cut with 5 different restriction enzymes (Eco RI, Hind
III,Bam HI,PstI and BglII)was also purchased from
Clonetech.
a- and 7-"P-dATP and a-"P-dCTP were purchased from New
England Nuclear,Boston Mass. An oligonucleotide-primed
extension labeling kit was purchased from Boehringer Mannheim.
Bovine serum and fetal bovine serum were purchased from Gibco
Laboratories.F12 nutrient mixture and DMEM were purchased
from Gibco Laboratories, Grand Island, N.Y. Insulin and
transferrin were purchased from Sigma Chemical Company, St
Louis, Mo.A synthetic degenerative oligonucleotide probe
complementary to codons 5 through 12 of the base sequence of
human S-protein was prepared on an Applied Biosystems28
synthesizer and purified at the OSU Gene Research Program.
Isolation of human S-protein cDNA clone from a gill cDNA
library of HepG2 mRNA
A human hepatoma cDNA library was screened for human S-protein
sequences by in situ hybridization (Davis et al., 1986) using
a degenerative oligonucleotide probe derived from the amino-
terminal sequence of human S-protein (Jenne and Stanley, 1985;
Suzuki et al., 1985; Barnes et al.,1983c).The lambda gtll
vectors contained greater than 1 million inserts ranging in
size from 600 to 4000 bases.Approximately ten thousand
plaques were plated and screened with radiolabeled probe. The
oligonucleotide probe was end-labeled using T4 polynucleotide
kinase in the presence of 11-"P dATP (specific activity > 10°
cpm/gg).
Hybridization was conducted at 55°C for 16 hours in the
presence of 2 X SSC, 0.2% polyvinyl pyrrolidone (PVP), 10 X
Denhardt's solution, sonicated salmon sperm DNA (150 µg /ml),
yeast RNA (1.7 mg/ml)and 106 cpm/ml radiolabeled probe.
Blots were washed after hybridization with 2 X SSC at 42°C and
twice at 35°C for 30 minutes each (Davis et al., 1986).After
the tertiary screening of positive hybridizing colonies,
single plaque-purified representations of human S-protein
cDNA-lambda gtll clones were obtained.29
Subcloning of human S-protein cDNA and the 5'-end 564-base
fragment of human S-protein into pUC18
The human S-protein cDNA clone was subcloned into the Eco RI
site in the polylinker region of 1=18 (Davis et al., 1986).
The 5'-end 564-base fragment of human S-protein cDNA was
subcloned into the Eco RI and Kpn I sites in the polylinker
region of pUC18.Since digesting the Kpn I generates three
fragments that are of similar size, the human S-protein cDNA
was first digested with Cla I, the 5'-end fragment was then
isolated and digested with Kpn I.
Competent DH5 a cells (lacZ -) were transfected with the
human S-protein-p0C18 clone (HSP-pUC18) and the 5'-end of
human S- protein -pUC18 (HSP564- pUC18).Successful ligation of
insert into pIIC18 disrupted the plasmid's ability to cleave 13-
galactosidic bonds, which resulted in loss of blue colony
formation on X-gal agar plates (Davis et al., 1986).
Isolation of cytoplasmic RNA and preparation of RBA Blots
Cytoplasmic RNA was isolated from cell lines as described
(Rosenthal et al., 1986).Cells were grown in the presence of
10% calf serum or 10% fetal bovine serum. Isolated RNA
samples were analyzed by electrophoresis through a 1.2%
formaldehyde/agarose gel.2.5 lig of poly A-selected mRNA or
20 gg total RNA were run on a 1.2% formaldehyde/agarose gel,
andtransferredtonitrocellulosebystandardmethods
(Southern, 1975).30
DNA and RNA blot hybridization
Hybridization of DNA and RNA blots were performedby standard
methods (Southern, 1975).Nylon blots containing genomic DNA
were prehybridized for 4 hoursin the presence of 6 X SSC, 10
X Denhardt's solution, 100 µg /mlsonicated salmon sperm DNA
and 0.5% SDS at 65°C.Nitrocellulose blots containing poly A-
selected mRNA or total RNA wereprehybridized for 4 hours in
the presence of 50.0% deionized formamide,50 mM sodium
phosphate (pH 6.5), 0.8 M NaC1, 1.0 mM EDTA,0.1% SDS, 10 X
Denhardt's solution, 250 µg /ml sonicated salmon spermDNA and
500 µg /ml yeast RNA at 57°C.The cDNA inserts of HSP-pUC18
and HSP564-pUC18 were radiolabeled(specific activities > 108
cpm/gg) by oligonucleotide-primed extensionin the presence of
a-32P-dATP and a-32P-dCTP, and were purified on a Sephadex G50
column.
The DNA blots were hybridized for 16-20 hoursat 65°C
with 1.5 X 106 cpm/ml radiolabeled HSP-pUC18 cDNAinsert and
fresh hybridization buffer. The RNA blots werehybridized for
16-20 hours at 57°C with 2.0 X 106 cpm/mlradiolabeled HSP564-
pUC18 cDNA insert and fresh hybridization buffer.DNA blots
were washed at 65°C with 2 X SSCfor 15 minutes, and then
washed with 2 X SSC and 0.1% SDS for 30 minutes.Stringent
washes were then done at 65°C with either 0.5 X SSCand 0.1%
SDS, 0.25 X SSC and 0.1% SDS or 0.1 X SSCand 0.1% SDS as
indicated in the figure legends.
RNA blots werewashed twice at room temperature with 1 X31
SSC, 0.1% SDS for 3 minutes, and then washed twice at 65°C
with either 0.5 X SSC, 0.1% SDS or 0.1 X SSC, 0.1% SDS.The
blots were wrapped in plastic and exposed to film overnight or
longer at-80°C in an X-ray film cassette containing an
intensifying screen.32
RESULTS
Southern blot analysis
A human HepG2 cDNA library was screened with a radiolabeled
oligonucleotide probe containingthe nucleotide sequence
derived from the amino-terminal portion of human S-protein
(Jenne and Stanley, 1985; Hayman et al., 1983; Barnes et al.,
1983c).Three full length human S-protein cDNA-lambda clones
were purified separately after the tertiary screening.The
cDNA insert of one of these clones was subcloned into the Eco
RI site of pUC18 (HSP- pUC18), and the 5'-end 564 fragment of
the human S-protein cDNA was subcloned into the Eco RI and Kpn
I site of pUC18.
Figure 2.1 shows the ethidium bromide-stained restriction
fragments from HSP-pUC18 after digesting with Eco RI alone or
in combination with either Kpn I,Cla I or Acc I. The
restriction fragment sizes are identical to those predicted
from the reported sequence of human S-protein cDNA (Jenne and
Stanley, 1985).Digesting with Eco RI alone generated the 2.7
Kbp pUC18 vector and the 1.54 Kbp human S-protein cDNA insert.
Digesting with Eco RI and Kpn I produced the 2.7 Kbp plasmid
and 3 fragments of approximately 410 bp, 560 by and 570 bp.
Digesting with Eco RI and Cla I produced the 2.7 Kbp plasmid
and two fragments of approximately 600 and 940 bp.Digesting
with Eco RI and Acc I produced the 2.7 Kbp plasmid and 233
fragments of 740 by and 800 bp.Digesting with Eco RI and
either Hind III, Sma I, Pst I or Bam HI produced the 2.7 Kbp
plasmid and the full 1.54 Kbp human S-protein cDNA insert (not
shown).
Southern hybridization of radiolabeled probe with human
placental genomic DNA identified single bands that hybridized
under stringent conditions in each of the lanes containing DNA
digested with 5 different restriction enzymes (Fig 2.2a).The
following bands were detected:Eco RI-digested DNA, 20-21 Kbp
band; Hind III-digested DNA, 17-18 Kbp band; Bam HI-digested
DNA, 9.0-9.5 Kbp band; Pst I-digested DNA, 2.3-2.5 Kbp band;
Bgl /I-digested DNA, 13-14 Kbp band.The sizes of the bands
produced from digesting with Eco RI, Hind III, Pst I and Barn
HI are the same as those previously reported for human genomic
DNA from peripheral blood lymphocytes (Jenne and Stanley,
1987).
Southern blot analyses of mouse genomic DNA digested with
Eco RI, Hind II or Bam HI identified single bands of sizes
7.0-7.5 Kbp, 5.5-6.0 Kbp and 3.5-4.0 Kbp respectively (Fig.
2.2b).Since digesting with each of the three restriction
endonucleases yielded a single band no greater than 7.5 Kbp in
size, it is likely that mouse S-protein is a single copy gene.
Jenne and Stanley have previously made a similar conclusion
based on similar analysis (Jenne and Stanley, 1987).
A DNA blot containing the Eco RI-digested genomic DNA of
human, monkey, rat, mouse, dog, cow, rabbit, chicken and yeast34
was hybridized with radiolabeled human S-protein cDNA (Fig.
2.3).After washing at low stringency (2 X SSC, 0.1% SDS) and
exposing the blotto film overnight,single bands were
detected in DNA from rat (7.0-7.5 Kbp), mouse (5.5-6.0 Kbp),
dog (18-19 Kbp), cow (5.5-6.0 Kbp) and rabbit (9.5-10 Kbp).
Thesebandswerestillpresentafter washingathigh
stringency(0.25XSSC,0.1% SDS)(Fig2.3). Atlow
stringency, high background hybridization was observed in
human and monkey Eco RI-digested DNA. At high stringency (0.1
X SSC, 0.1% SDS) single bands in lanes containing the monkey
(5.5-6.0 Kbp) and human (20-21 Kbp) DNA were detected.
Northern blot analysis
Northern blots analyzing total RNA or mRNA of human and mouse
tissues and cultured cells were hybridized with radiolabeled
HSP564 cDNA.A single 1.7 Kb S-protein mRNA was detected in
human liver mRNA after an overnight exposure (Fig. 2.4); no S-
protein mRNA was detected in human lung,placental and
leukocyte mRNA after a two week exposure.A 1.7 Kb mRNA for
S-protein in human liver has previously been reported (Jenne
and Stanley,1987).A single 1.6 Kb S-protein mRNA was
detected in mouse liver mRNA after an overnight exposure and
a faint S-protein mRNA band was detected in mouse brain after
5 days exposure (Fig 2.5).No S-protein mRNA was detected in
RNA from mouse skeletal muscle, heart, kidney and testis mRNA
after several weeks exposure.35
Human S-protein mRNA was detected in RNA from the human
hepatoma cell-line PLC/PRF5 after an overnight exposure (Fig.
2.6a).No human S-protein mRNA was detected in total RNA from
cultured RD rhabdomyosarcoma, foreskin or IMR9 fibroblasts
after 6 days.After the final exposures, the nitrocellulose
blots were stripped for 30 minutes at 80°C in a 1.0% glycerol
solution and reprobed with 0-actin to examine the integrity of
the mRNA.In all cases, there was little or no degradation
detectedinthesamples. Figure2.6bshowsthe
autoradiographs of human foreskin, PLC/PRF5, RD and IMR9 total
RNA probed with (3 -actin after two days exposure.36
DISCUSSION
Human S-protein is a multidomain serum glycoprotein with
diverse functions.The first 44 amino acids of its amino-
terminus contains the entire somatomedin B peptide (Jenne and
Stanley, 1985; Suzuki et al., 1985; Barnes et al., 1983c);
directly following is the cell-binding site that permits cell
attachment and spreading (Hayman et al., 1985).The carboxy-
half of S-protein contains complement-binding and heparin-
binding domains (Jenne and Stanley,1985).The human S-
protein gene contains eightexons and7intronsin an
arrangement and sequence related to hemopexin (Jenne and
Stanley, 1987).
In this paper we report that the gene for S-protein is
present in other mammals, including monkey, rat, mouse, dog,
cow and rabbit.The S-protein gene was not detected in
chicken or yeast genomic DNA, but this does not exclude the
possibility that the analogous protein shares homology with
mammalian S-protein in some conserved regions.Immunological
cross-reactivity between human and chicken hemopexins has been
observed (Chen et al., 1988).
Human S-protein is synthesized by the liver and is found
in serum at a concentration of 100-400 µg /ml (Suzuki et al.,
1985; Jenne and Stanley, 1987; Barnes et al., 1985; Shaffer et
al.,1984).Hayman et al.(1983) reported that S-protein37
could be detected in cultured fibroblasts as well as in
muscle,kidney,lung and placental tissue.However, our
Northernhybridizationanalysessuggestthatcultured
fibroblasts do not produce mRNA for human S-protein at a level
detectable after several days exposure.Additionally, no
message was detected in RNA from muscle, kidney orplacenta.
These results suggest that matrix-bound S-protein identified
by immunologicalor other methods may derivefrom the
circulation in vivo or from serum in vitro, possibly by
interaction ofS-protein with matrix componentsthrough
binding sites on the molecule for other matrix proteins or
through interaction with plasminogen activator inhibitor,
which is secreted by many cell types.Our results are in
agreement with our previously reported failure to detect S-
protein in cultured fibroblasts, kidney or muscle-derived
cells (Barnes et al., 1985).
Both human and mouseliver produce S-protein mRNA
detectable after an overnight exposure; a low level of S-
protein mRNA also was detected in mouse brain mRNA.The cell
type that produces S-protein mRNA in mouse brain is unknown.
We could detect no immunological reactivity to spreading
factor in a human neuroblastoma line (Barnes et al., 1985).
Fibronectin and possibly other adhesion proteins have been
detected in cultured astrocytes (Price et al.,1985), and
filial cells may be the source of brain S-protein.However, we
were unable to detect S-protein mRNA in one astrocytecell38
line tested.Further work will be necessary to determine the
cell type synthesizing S-protein in the brain.39
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ADDITIONAL COMMENTS
Although we detected S-protein in mouse brain mRNA, we
were unable to detect the message in SFME proastroblasts.
Recently, it has been demonstrated that TGF p increases the S-
protein mRNA in HepG2 cells.TGF 13 did not induce S-protein
in SFME that we could detect by Northern analysis. The
distribution and regulation of S-protein in the brain remains
to be determined.Recently, S-protein and its receptor was
detected at high levels in the brains of Alzheimer's disease
victims.It is suggested that this protein may play a role in
inflammatory responses associated with the disease. S-protein
andit'sreceptorhavebeenrecentlydetectedinthe
astroglial-derived tumor, glioblastoma multiforme, which may
potentiate glioblastoma cell invasion of normal brain (Gladson
and Cheresh, 1991). The mouse S-protein cDNA has recently
been isolated and used as a probe for S-protein in the mRNA of
fourteen different mouse tissues, including liver, lung and
brain (Seiffert et al.,1991).S-protein mRNA was only
detected in the liver.Based on a dose response analysis, the
authors reported that the other tissues examined contain at
least 40-fold less S-protein than the liver.Hayman et al.
(1983) reported the detection of vitronectin (S-protein) by
immunofluorescence in the human diploid fibroblast cell line,
IMR90.However, we could not detect the mRNA for S-protein in41
the IMR90 cell line.Barnes and Reing (1985) also could not
detecttheproteininIMR90cellsusingenzyme-linked
immunoassay techniques.Enzyme-linked immunoassay is a very
sensitive method for detecting a protein.Since each enzyme
molecule acts catalytically to generate many thousands of
molecules of product, this technique allow even tiny amounts
of antigen to be detected.I have examined the sensitivity
of Northern blot experiments in our laboratory using 32P-
radiolabeled probe (specific activity > 10° cpm/gg), and I
estimate that I should be able to detect femtogram amounts of
a single mRNA type after several days exposure.I believe the
sensitivityofNorthern blotmethodsiscomparableto
immunofluorescent detection of the corresponding protein.
Using monoclonal antibodies directed towards human S-protein,
Hayman et al.(1983) could not detect the bovine S-protein
present in the serum used to culture the IMR90 cell line.
However, they detected what appeared to be a fibrillar-like
pattern of S-protein associated with the cell surface of IMR90
cells and surrounding extracellular matrix.It may be that
bovine S-protein's interaction with the extracellular matrix
maychangeit'sconformationsuchthatthemonoclonal
antibodies directed to human S-protein can recognize this
bovine serum-derived protein.The authors did not report
whether other cell line,such as epithelial-derived cell
lines, were negative as controls.We can detect the gene for
S-protein in cow using human S-protein cDNA as probe, and42
there should be conserved regions in certainfunctional areas
of both proteins,like the cell attachment site,that a
monoclonal antibody could recognize. If,in fact,the
monoclonal antibodies used by Hayman et al. (1983) were not
detecting S-protein derived from the serum, it may be that the
particular batch of serum used in their experiments contained
a unique factor not present in our systemthat was recognized
by the monoclonal antibodies, or was responsiblefor the
expression of S-protein in the fibroblast cells that they
examined.123 4 5
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Fig.2.1: Characterization ofhuman S-protein cDNA by
restriction enzyme digestion analysis.Human S-protein cDNA-
pUC18 fractionated on an 0.8% agarose gel and stained with
ethidium bromide after digesting with 4 different restriction
enzymes.Lane 1, Eco RI and Acc I double digested HSP-pUC18;
lane 2, Eco RI and Cla I double digested HSP-pUC18; lane 3,
Eco RI and Kpn I double digested HSP-pUC18; lane 4, Eco RI
digested HSP-pUC18; lane 5, Hind III-digested lambda DNA (size
markers).44
Fig. 2.2:Southern blot analysis of human and mousegenomic
DNA probed for the S-protein gene. (A) Anautoradiograph of a
Southern blot containing human placental genomic DNAdigested
with the indicated enzymes.The blot was hybridized with
radiolabeled human S-protein cDNA (HSP -pUC18 cDNA) for 2hours
and then washed under stringent conditions (0.1 X SSC,0.1%
SDS, 65°C).Lanes 1-5 contain Eco RI, Hind III, Ham HI, Pst
Iand Bgl II-digested genomic DNA,respectively.(B)An
autoradiograph ofBalb/c mouse genomicDNA probed with
radiolabeled human S-protein cDNA and washed understringent
conditions (0.5 X SSC, 0.1% SDS,65°C).Lanes 1,2 and 3
contain Eco RI, Hind III and Ham HI-digestedgenomic DNA
respectively. The positions of lambda DNA (Hind /II- digested)
molecular weight markers are shown.-23.1 Kb
_9.4 Kb
-6.6 Kb
_4.4 Kb
B
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Fig. 2.3: The gene for S-protein detected in genomic DNA of
seven mammals.Radiolabeled human S-protein cDNA (HSP-pUC18
cDNA) was used to probe the genomic DNA of yeast (1), chicken
(2), rabbit (3), cow (4), dog (5), rat (6), mouse (7), monkey
(8) and human (9) digested with Eco RI and blotted onto nylon.
The hybridized blot was washed with 0.25 X SSC, 0.1% SDS at
65°C.1234
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Fig. 2.4: Northern blot analysis of the mRNA from several
human tissues probed for human S-protein.Autoradiograph of
aNorthern blotcontaining 2.5lighuman leukocyte(1),
placental (2), liver (3) and lung (4) poly A mRNA probed with
radiolabeled human S-protein (5'-end 564-base fragment) cDNA.
After hybridization, the blot was washed with 0.5 X SSC, 0.1%
SDS at 65°C and exposed to film.After an overnight exposure,
a single band of 1.7 Kb was detected in the human liver mRNA
lane.28S ribosomal RNA is 5.1 Kb and 18S ribosomal RNA is
2.0 Kb.123456
-28S
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Fig. 2.5:Northern blot analysis of the mRNA from several
mouse tissues probed for S-protein. Autoradiograph of a
Northern blot containing 2.5 !iv mouse testis (1), liver (2),
kidney (3), heart (4), brain (5) and skeletal muscle (6) poly
A mRNA after probing with radiolabeled human S-protein (5'-end
564-base fragment). After hybridization, blots were washed at
high stringency (0.5 X SSC, 0.1% SDS at 65°C) and then exposed
to film.The autoradiograph was developed after exposure for
14 days.A single band of 1.6 Kb was detected in the mouse
liver (strong band) and mouse brain (faint band) mRNA.A
123 4
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Fig. 2.6: Northern blot analysis of the mRNA from several
human cell-lines probed for human S-protein and(3- actin.
Autoradiograph of a Northern blot containing 2.tg total RNA
from human foreskin (1), PLC/PRF5 (2), RD (3) and IMR9(4)
cell lines probed with radiolabeled human (5'-end 564-base
fragment)(A) and13 -actin (B).After hybridization, blots
were washed at high stringency (0.1 X SSC, 0.1% SDS at 65°C)
and then exposed to film.After an overnight exposure, a
single band of 1.7 Kb for human S-protein mRNA was detected.50
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SUMMARY
Differential screening of cDNA library derived from mRNA
of TGF 13-treated serum-free mouse embryo (astrocyte precursor)
cells isolated a strongly TGF (3- regulated mRNA that codes for
cystatin C,a cysteine protease inhibitor. Increase in
cystatin C mRNA level was observed within four hours after
treatment with picomolar concentrations of TGFp. The
increase was reversible upon removal of TGF 13and was not
prevented by cycloheximide. These resultssuggestthat
cystatinCexpressionmayrepresentadevelopmentally
regulated differentiated function of astrocytes, and also
suggest that cystatin C expression may be involved in the
response of brain cells to platelet release of TGF13 after
trauma or injury.52
INTRODUCTION
The Balb/c serum-free mouse embryo (SFME)cell line is
cultured in basal nutrient medium supplementedwith insulin,
transferrin, epidermal growth factor, high densitylipoprotein
and fibronectin (Loo et al., 1987; Loo et al.,1989a; Loo et
al., 1989b; Loo et al., 1990; Shirahata et al.,1990; Rawson
et al., 1990; Sakai et al., 1990).Unlike conventional mouse
embryo cell lines derived in serum-containingmedium, these
cells do not exhibit growth crisis or grosschromosomal
aberrations(Looetal.,1987;Looetal.,1989).
Proliferation of SFME cells is reversibly inhibited by serum
(Loo et al., 1987; Loo et al., 1990; Shirahata et al.,1990;
sakai et al., 1990), and treatment of SFME cells with serum or
transforming growth factor p (TGF (3) leads to the appearance
of filial fibrillary acidic protein, a specificmarker for
astrocytes (Sakai et al., 1990; De Vellis et al.,1986).TGF
f3is a platelet-derived serum peptide growth factor that
affects proliferation and differentiation of a varietyof cell
types (Sporn and Roberts, 1988; Rizzino, 1988).
We constructed a cDNA library from mRNAisolated from
SFME cellsafter treatment with TGFpand selected by
differential screening clones representing TGF 13- regulated
mRNA.A clone markedly regulated by TGF p in SFMEcultures53
was identified as cystatin C, a member of a family ofcysteine
protease inhibitors that also includes the prohormone
kininogens(Barrett,1987;Rawlingsand Barrett,1990).
Cystatin C is a major central nervous system-derived component
of cerebrospinal fluid and is the predominant constituent of
amyloidfibrilsinbrainsofpatients withaformof
hereditary cerebral hemorrhage (Ghiso et al., 1986; Cole et
al., 1989; Maruyama et al., 1990).The protein also modulates
leukocyte chemotaxis and phagocytosis-associated respiratory
burst and has been suggested to be a regulator in inflammatory
processes(Leung-Tack etal.,1990a;Leung-Tack etal.,
1990b).54
METHODS
Procedures for culture of Balb/c SFME cells have been
described in detail in Loo et al. (1987), Loo et al. (1989a),
Loo et al.(1989b). RNA isolation was done as follows.
Cells growing in plastic dishes were washed twice with ice-
cold PBS.They were then gently scraped off the dish (in 1-2
ml of PBS) with a rubber policeman, and pelleted.Cells were
suspended in 140 mM NaCl /1.5 mM MgC12/10 mM Tris HC1, pH 7.6/
200 µg /ml heparin (Sigma Chemical Company, MO) and lysed by
adding 0.5% Nonidet P-40 (Sigma Chemical Company, MO).After
brief mixing the lysate was centrifuged at 400 x g for 1 min.
10% SDS and 10 mM EDTA was added to the supernatant followed
by extraction twice each with phenol, phenol/chloroform (1:1),
andchloroform/isoamylalcohol(24:1). TheRNAwas
precipitated by adding 2.5 vol of 95% ethanol and 0.3 M sodium
acetate (pH 6.0). Residual DNA was removed with RNAse-free
DNAse I in the presence of vanadyl riboside complex (both from
Bethesda Research Laboratories, MD).
Preparation of a TGF (3- inducible cDNA library
A cDNA library in bacteriophage lambda gtll was prepared using
a cDNA synthesis kit (Pharmacia) .The library was prepared
from mRNAofSFME growninserum-free F12/DMEM medium
containing HDL (10 µg /ml), insulin (10 µg /ml), transferrin (2555
µg /ml) and EGF (50 ng/ml) in dishes precoatedwith bovine
fibronectin (10 µg /ml) supplemented additionally with 10 ng/ml
TGF 0 for 48 hours.The mRNA was purified from approximately
1.0 mg of total RNA using an oligo-dT column (BRL).3.0 gg of
this mRNA was used in the synthesis of cDNA in the presence of
a-32P-dCTP.First-strand cDNA synthesis was performed with
Moloney murine leukemia virus reverse transcriptase andoligo
d(T)12-18 as primer.Second-strand synthesis involved a
modification of the procedure of Gubler and Hoffman (1983).
A portion of this cDNA was run on an agarose gel alongwith
molecular weight markers and exposed to film;the major
portion of the cDNA ranged between 0.5 to 2.0 Kbp, although
some higher molecular weight cDNA up to 5.0 Kbp wasobserved.
The cDNA was linked to EcoRI adaptors containing internal Not
Isites,and a portion was ligated to gtll lambda arms
(Promega) overnight.The library was packaged into Promega
Packagene.The titer of the library was determined by
transfecting an overnight culture of Y1090 bacteria grown in
the presence of 10 mM MgSO4 and 0.2% maltose with several
different amounts of packaged library.The library was found
to contain over 1 million independent clones andapproximately
70% of the individual plaques contained cDNA.The library was
plated on LB-agarose 150 cm plates to approximately 500
plaques per plate using the bacteria host Y1090.Duplicate
nitrocellulose filter lifts were taken from each plate, and
the cDNA was denatured in 0.2 M NaOH, 1.5 M NaC1 for 5 min.,56
neutralized for 5 min. in 0.4 M Trio HC1 (pH7.4), 2 X SSC and
washed for 5 min. in 2 X SSC.The filters were dried for one
hour and then baked at80°C for an additional2hours.
Radiolabeled single-stranded cDNA probes weresynthesized
using as template 1.0 gg mRNA from SFMEcells cultured in
serum-free medium with or without 10 ng/mlTGF (3 for 48 hours.
The reaction included 100 mM Tris HC1(pH 8.6), 125 mM KC1, 10
mM MgCl 2.5 mM DTT, 1 mM dATP,dGTP, dTTP, 1 gg oligo(dT),
1 unit RNAsin and 100 LCi a-32P -dCTP (3000 Ci/mmol).The
mixture was incubated at 42°C for 2 hours,the mRNA was
hydrolyzed with 25 gl 0.15 M NaOH at 65°C for 1hour, and the
radiolabeled cDNA was purified on a SephadexG50 column.
Specific activities ranged between 1 to 3 x109 cpm/ug mRNA
forbothprobes. Differentialscreeningofduplicate
nitrocellulose filters was performed using 2-3 x107 cpm of
the radiolabeled probes in hybridizationbuffer containing 10%
dextran sulfate, 40% formamide,4 X SSC,10 X Denhardt's
solution,0.2 M Tris HC1(pH 7.4),1.0 µg /ml poly(dA)
(Pharmacia) and 200 µg /ml sonicated salmon sperm DNA.Filters
were first prehybridized inhybridization buffer for 4 hours,
and then hybridized at 42° C for 3 days. Plaques that were
detected by the TGF (3- induced cDNA probe and notby the serum-
free cDNA probe were selected and twicerescreened.
Subcloning of Mouse Cystatin C
One of 14 positive tertiary screeneddifferential plaques was57
used to transfect an overnight culture of Y1090 bacteria.
Bacteriophage DNA was purified from the lysed plates using
LambdaSorb Phage Absorbent provided by Promega.The cDNA
insert was subcloned into the EcoRI site of the polylinker
region of pUC18 and competent DH5a (Clonetech) cells were
transfectedwithaportionoftheligationmixture.
Successful insert ligation into pUC18 resulted in the loss of
blue colony formation on X-gal agar plates with the appearance
oflarger,white colonies. Single white colonies were
selected and grown in an overnight culture in LB broth
(ampicillin, 100 µg /ml).Plasmid DNA was purified by alkali
hydrolysis of the bacteria and subsequent CsC1 gradient
centrifugation. ThecDNAinsertwasdeterminedtobe
approximately 660 by by agarose gel electrophoresis analysis.
Sequencing of Mouse Cystatin C
The CsCl-purified plasmid preparation was used as a template
for sequencing the cDNA insert in both the forward and reverse
directions using the Sequenase method of the United States
BiochemicalCorporationfordideoxy-doublestrandedDNA
sequencing.The reactions were conducted in the presence of
a-35S-dCTP(800Ci/mmol),andwererunona6.0%
polyacrylamide gel.The gel was fixed, baked and exposed to
film for 18-72 hours at -88°C using an intensifying screen
cassette.Sequences in the middle portion of the cDNA were
determined by preparing an exonuclease-digested clone that had58
lost the initial 150 bases using the Erase-a-Base system of
Promega. Also,a confirmation of the full sequence was
provided by the Center for Gene Research at the Oregon State
University using an automated laser sequencer. Cystatin C was
quantified as described (Lah et al., 1989), using as standard
chickenegg whitecystatin(Sigma),(seeAppendixfor
details).59
RESULTS
Differential plaque screening of approximately 104 cDNA
clones of mRNA from SFME cells cultures for 48 hours in serum-
free medium with TGF p identified 14 bacteriophage clones that
hybridized more strongly through tertiary screens to probe
derived from TGF 13 treated cells than to probe derived from
cells not exposed to TGF p (Fig. 3.1).The cDNA insert (660
bp) from one bacteriophage clone was recloned into pUC18.
Radioactively labeled insert from this clone was used to
screen the other positive clones, and all were found to cross-
hybridize to this insert, suggesting that the mRNA represented
by this clone was strongly regulated by TGF p.
Northern blots confirmed that the mRNA recognized by the
clone was markedly increased in SFME cells after exposure to
TGF p (Fig. 3.2a).Message size was approximately 0.8 Kb.
Increased message level was detected after a 4 hour incubation
of SFME cells with TGF p (Fig. 3.2a).The increase in message
was reversible upon removal of TGF p from the culture medium.
No increase in the level of this message was seen in an
identical experiment using Balb/c 3T3 and 10T1/2 mouse cells
(Fig.3.3).TGF p at 1.0 ng/ml produced a near maximal
response in SFME cells(Fig.3.4), and exposure to nerve
growth factor (10 ng/ml), platelet-derived growth factor (1060
ng/ml) or fibroblast growth factor (10 ng/ml) for 24hours did
not lead to increase in the message levels(Fig 3.5).
Figure 3.6 represents a Northern analysis of SFME grown
in the presence and absence of TGF 1 when protein synthesisis
inhibited.Although cystatin C mRNA is still induced by TGF
pin the presence ofcycloheximide,GFAPinductionis
abolished.This may indicate differential regulation of the
two genes by TGF f3.
Determination of the nucleotide sequence of the cDNA
clone of the TGF 13-regulated mRNA identified 3'and5'
untranslated regions,translation start and stop codons,
consensusinitiationsequence, signalsequenceand
polyadenylation signal (Fig. 3.7).The cDNA sequence for the
mouse cystatin C showed 88% homology to ratcystatin C and 73%
homology to human cystatin C (Cole et al., 1989; Abrahamson et
al., 1987).Assay of culture medium from TGF 3- treated SFME
cellsconfirmedthatthegrowthfactorregulatedthe
appearance of the secreted protein (Fig. 3.8).Northern blot
hybridization analysis of mRNA from various mouse tissues with
the cDNA as probe confirmed high levels of a 0.8 Kb message
expressed in brain, and also in heart and lung (Fig. 3.9).
Differentiated astrocytes in primary culture recently have
been reported to produce cystatin C (Zucker-Franklin et al.,
1987), although no regulation was explored in this system.61
DISCUSSION
In other cell culture systems TGF p suppresses synthesis
of proteases and stimulates synthesis of inhibitors of serine
or metalloprotease (Denhardt et al., 1986; Edwards etal.,
1987; Lund et al., 1987; Kerr et al., 1988).Our work shows
that in SFME cells TGF p can stimulate the appearance of a
member of another class of protease inhibitors.TGF p also
increases production of extracellular matrix in some cell
types, and regulation of synthesis of proteases and inhibitors
may stabilize the increased deposition of extracellularmatrix
components in the central nervous system (De Vellis et al.,
1986),and part of the function of TGF p regulation of
cystatin C in astrocyte precursors may be to assist in the
protection of extracellular matrix.
Cystatin C also exerts effects on the immune response
(Leung-Tack et al.,1990a; Leung-Tack et al.,1990b), and
increased production of cystatin due to TGF p released by
platelets in response to injury or trauma may additionally
protect tissue in the area of a wound from cathepsin released
by damaged cells.In addition, cystatin C and other protease
inhibitors,aswellasthecystatinCtargetprotein
cathepsin, have been implicated in the development of amyloid
depositsin brain associated with Alzheimer diseaseor62
cerebral hemorrhage (Ghiso et al., 1986; Cole et al.,1989;
Maruyama et al., 1990; Meier et al., 1989; Cataldo etal.,
1990; Abraham et al.,1988; Wagner et al.,1989). Data
presented here regarding regulation of cystatin C, takenwith
this previous work, suggests a possible role for TGFp in the
etiology of some amyloid-associated brain diseases.63
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Fig. 3.1:Protocol for differential screening of a TGF (3-
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Fig. 3.2:Northern experiment examiningthe time course of
cystatin C induction byTGF p and reprobed with (3-actin.
SFMEcells weretreated with TGF 13(10ng/ml),20 lAg
cytoplasmic RNA was isolatedand Northern hybridizationblot
analysis carried out usingas probe a cDNA clone identifiedas
representing a TGF 13-regulatedmRNA by differential screening
of a library derived fromTGF (3- treated SFME mRNA.Top: (A),
no TGF p, 48 hour incubation; (B),TGF 13,4 hours; (C), TGF 13,
16 hours;(D) TGF p, 24 hours; (E)TGF p, 48 hours; (F),TGF
p24 hour,followed by 24 hour incubationwithout TGF13.
Bottom: reprobed with (3- actin.66
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Fig. 3.3:NIH 3T3 and 10T1/2 cells are not induced by TGF p
for induction of cystatin C mRNA.NIH 3T3 and 10T1/2 cells
were grown in serum-free medium for 48 hours.TGF p(10
ng/ml) was added for an addition 48 hours to half of the
cells.ABC DE
-Cystatin C
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Fig. 3.4: Northern experiment examining the dose response for
cystatin C induction by TGF 3.SFME cells were treated for 24
hours with or without TGF p and 20 µg cytoplasmic RNA analyzed
as described in Fig. 8.Top:(A), no TGF 13;(B), 10 pg/ml
TGF p;100 pg/ml TGF p;(D), 1 ng/ml TGF P;(E), 10 ng/ml
TGF p.Bottom: reprobed with [3- actin.A B C D
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Fig. 3.5:Other growth factors do not induce cystatin C in
SFME.Cells were grown serum-free in the presence of the
following growth factors for 24 hours.(A), TGF p (10 ng/ml);
(B),bFGF(10 ng/ml);(C),NGF(10 ng/ml);(D),PDGF(10
ng/ml).1 2 34
- GFAP
- cysC
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Fig. 3.6:Cystatin C mRNA induction by TGF p is not abolished
by cycloheximide treatment.SFME cells were treated with TGF
p(10 ng/ml) with or without cycloheximide (10 µg /ml), and
cytoplasmic RNA analyzed as described in Fig. 3.2.(1), no
TGF porcycloheximide; (2),TGF 13, 8hours; (3)
cycloheximide, 8 hours; (4), cycloheximide and TGF 13,8 hours.
Northern blot probed with a-32P-radiolabeled GFAP cDNA and
cystatin C cDNA.70
TTTATCCCTTTGTCCTAGCCAACC ATG GCC AGC CCG CTG CGC TCC TTG CTG TTC CTG CTG
Met Ala Ser Pro Leu Arg Ser Leu Leu Phe Leu Leu
GCC GTC CTG GGC GTG GCC TGG GCG GCG ACC CCA AAA CAA GGC CCG CGA ATG TTG
Ala Val Leu Gly Val Ala Trp Ala Ala Thr Pro Lys Gln Gly Pro Arg Met Leu
-1+1 10
GGA GCC CCG GAG GAG GCA GAT GCC AAT GAG GAA GGC GTG CGG CGA GCG TTG GAC
Gly Ala Pro Glu Glu Ala Asp Ala Asn Glu Glu Gly Val Arg Arg Ala Leu Asp
20
TTC GCT GTG AGC GAG TAC AAC AAG GGC AGC AAC GAT GCG TAC CAC AGC CGC GCC
Phe Ala Val Ser Glu Tyr Asn Lys Gly Ser Asn Asp Ala Tyr His Ser Arg Ala
30 40
ATA CAG GTG GTG AGA GCT CGT AAG CAG CTC GTG GCT GGA GTG AAC TAT TTT TTT
Ile Gln Val Val Arg Ala Arg Lys Gln Leu Val Ala Gly Val Asn Tyr Phe Phe
50 60
GAT GTG GAG ATG GGC CGA ACT ACA TGT ACC AAG TCC CAG ACA AAT TTG ACT GAC
Asp Val Glu Met Gly Arg Thr Thr Cys Thr Lys Ser Gln Thr Asn Leu Thr Asp
70 80
TGT CCT TTC CAT GAC CAG CCC CAT CTG ATG AGG AAG GCA CTC TGC TCC TTC CAG
Cys Pro Phe His Asp Gln Pro His Leu Met Arg Lys Ala Leu Cys Ser Phe Gln
90 100
ATC TAC AGC GTG CCC TGG AAA GGC ACA CAC TCC CTG ACA AAA TTC AGC TGC AAA
Ile Tyr Ser Val Pro Trp Lys Gly Thr His Ser Leu Thr Lys Phe Ser Cys Lys
110
AAT GCC TAAGGGCTGAGTCTAGAAGGATCATGCAGATTGTTCCTTACTTGTGCTCCTTCCCTATAGTGT
Asn Ala
120
TTCATCTCGCAGAAGGGTGCTCCGGCTCTGGAGGGCACCGCCAGTGTGTTTGCACCAGGAGACAGTAAAGGA
GCTGCTGCAGGCAGGTTCTGCACATCTGAACAGCTGTCCCCTGGCTCCACTCTTCTTGCAGTACCTATCATG
CCTTGCTCALTIMAAGCGGCCGCGAA
Fig. 3.7: The complete nucleotide sequence of mouse cystatin
C cDNA and the deduced amino acid sequence.The putative
signal peptide appears before the amino-terminal alanine,
residue 1.The polyadenylation signal is underlined.A
consensusinitiationsequence(ACCATGG)appearsatthe
translation start site.40
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Fig. 3.8:Cystatin C in culture medium from TGF 0-treated
SFME cells. Medium from cells treated for the indicated times
with TGF f3(10 ng/ml) was assayed for cystatin C by a
quantitativeassayofinhibitionofpapain-mediated
proteolysis, using as standard chicken egg white cystatin C.72
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Fig.3.9:Northern analysis of cystatin C expression in
various mouse tissues. (A) 20 µg total RNA of SFME with TGF
(48 hours, 2 ng/ml) (B) 20 µg total RNA of SFME with 10 % calf
serum, 24 h,(C) 5 µg mRNA of SFME with 10% calf serum, 24 h.
2 µg of poly A-containing RNA from (D) space,(E) testis,(F)
spleen,(G)skeletal muscle,(H)pancreas,(I)lung,(J)
liver,(K) kidney,(L) heart,(M) brain.73
CHAPTER IV
Gene Regulation of Cystatin C
SUMMARY
Cystatin C is induced to high levels in a serum-free
derived proastroblast cell-line known as SFME, in response to
transforming growth factor p.We were interested in examining
the regulation of the cystatin C gene with TGF3. By
inhibiting RNA polymerase II transcription by a-amanitin,
cystatin C mRNA decay was measured in the presence and absence
of the growth factor.It appears that cystatin C mRNA is
stabilized by TGF (3 compared to its observed decay when TGF p
is removed from the culture medium.The cystatin C cDNA was
cloned into a mammalian expression vector containing the
bacterial (3- galactosidase gene as a reporter under the control
of the Rous sarcoma viral promoter.We were unable to
regulate the constitutive expression of the lacZcysC transgene
by TGF (3,based on histochemical analysis. However, by
extended Northern blot exposures, we have detected a 4 Kb
message that hybridizes specifically to thecystatin C probe74
that is regulated by TGF R.This message possibly represents
the primary nuclear cystatin C transcript, and this suggests
that cystatin C is regulated in the nucleus.Cystatin C mRNA
is also induced by hydrocortisone in SFME grownunder serum-
freeconditions,althoughGFAPisnotinduced. DIA
(differentiation inhibitory activity), whichinduces GFAP in
SFME at comparable concentrations asTGF p, does not induce
cystatin C mRNA.75
INTRODUCTION
Transforming growth factor p is responsible for multiple
and cell-specific effects on the growth and differentiation of
many types of cells and tissues (Massague, 1990).Recently,
our laboratory (Sakai et al., 1990) has found that the serum-
free derived mouse embryo cell-line, known as SFME, will be
induced by TGFpto differentiate into astroblasts that
expresstheastrocyte-specificmarkerprotein,glial
fibrillary acidic protein(GFAP). Also,TGFpstrongly
induces the cysteine protease inhibitor, cystatin C, in SFME
(Solem et al., 1990).
A common feature of TGF p is the regulation of genes that
are a part of the extracellular matrix and itsconstruction
(Rizzino, 1988).These include the genes for fibronectin and
collagen (Raghow et al., 1987), and also certain proteases and
protease inhibitors, including plasminogen activator and its
inhibitor, metalloprotease andTIMP(tissue-specific inhibitor
of metalloprotease) are regulated by TGF p (Edwards et al.,
1987).The regulation of some of these genesis post-
transcriptional; often, mRNA stability is affected by TGF p
(Raghow et al.,1987; Penttinen et al.,1988).We were
interested in determining if TGF p regulates cystatin C in
SFMEbystabilizingmessengerRNA. Byinhibiting76
transcription with a-amanitin, we observe cystatin C mRNA is
stabilized by TGF p, but it is destabilized when TGF p is
removed from the culture medium.
Often, sequences within the mRNA of certain genes have
been associated with stability-regulation.Such is the case
for the transferrin receptor mRNA which contains sequences
known as iron response element (IRE) in the 3' untranslated
region (Mullner et al., 1989). Also, the cell-cycle regulated
expression of certain histone genes is due to the presence of
untranslatablemRNA sequences controllingregulated
destabilization (Morris et al., 1986; Ross and Kobs, 1986).
We were interested in determining if cystatin C mRNA contains
sequences that confer stability-regulation by TGF p.We have
constructed a mammalian expression vector containing the Rous
sarcoma virus long terminal repeat which drives the expression
ofthebacterialP-galactosidaseandcystatinCcDNA
(LacZcysC)transgene. We were unable to regulate the
transgene's constitutive expression by TGF in transient
transfection experiments. However,by theanalysisof
extended Northern blot exposures,an approximately 4Kb
message was detected that is regulated by TGF P; this may be
the primary cystatin C transcript based on its predicted size
(Abrahamson et al, 1990), which would suggest that there may
be regulation of cystatin C in the nucleus as well as the
cytoplasm.
Previously,we reported thatother growth factors,77
including nerve growth factor, platelet-derived growthfactor,
and basic fibroblast growth factor do notinduce cystatin C in
SFME(Solem et al., 1990). We find thatSFMEcells respond
to the addition of10-7 Mhydrocortisone with increased
expressionofcystatinCmRNA,andthisinductionis
comparable to that found byTGF 0.However,GFAPis not
induced by hydrocortisone.We have found by Western blot
analysisthatDIA(differentiationinhibitoryactivity)
inducesGFAPinSFME(Collodi, Nishiama and Barnes, personal
communications).We were unable to detect an increasein
cystatin C mRNA inSFMEgrown in the presence of DIA.Thus,
these two genes may be differentially regulatedinSFME.78
METHODS
RNA isolation and Northern blot analysis:
SFME were grown under standard serum-free conditions (Loo et
al.,1989); the addition of specific growth factors is as
indicated. SFME stably integrated clones containing the
pRSVcysC3' plasmid were selected in the presence of 200 µg /ml
G418 (Gibco/BRL). RNA isolation has previously been described
(see Chapter 3, methods). RNA was size-fractionated on a 1.2%
formaldehyde-agarose gel, and blotted onto nitrocellulose by
standard methods (Southern, 1975; Davis et al., 1986).All
RNA isolated from transient transfection experiments was
DNAsed with RNAse-free DNAse(Promega)as described(see
Chapter 3 methods in this dissertation).
Measurement of cystatin C mRNA stability:
SFME were grown 24 hours in the presence of TGF p (2 ng /ml),
the medium was then changed to medium without TGF p, and a-
amanitin(1 µg /ml) was added.TGF p was again added 15
minutes after a-amanitin addition to half of the plates.
After 0,3,6, and 8 hours of incubation, RNA was isolated,
DNAses, and 20 gg RNA samples were run on a gel for Northern
blot experiments.Hybridization was performed by standard
methods (Davis et al., 1986), and cystatin C and (3 -actin mRNA
was measured by exposing the blot to X-ray film.Quantitation79
of the messages was determined using the AMBIS system that
measures radioactivity, which is provided by the central
service laboratory of the Center for Gene Research at Oregon
State University.
Construction of the RSVLacZcysC plasmid:
pRc/RSV was purchased from Invitrogen, San Diego,CA.To
produce a plasmid with the lacZ gene fragment under the
direction of the RSV LTR, we cloned the 3.5 Kb lacZ fragment
from a Not I digestion of pCMVlacZ (Clonetech Laboratories,
Palo Alto, CA.) into the unique Not I site in the polylinker
region of pRc/RSV.The orientation of lacZ was determined by
restriction enzyme digestion analysis.The 660 by cystatin C
cDNA containing Not I linkers was cloned into the Not I site
at the 3' end of lacZ after first isolating a partial digest
of pRSVLacZ that had been linearized at the 5' end Not I site,
and removing the 5' Not I site by filling the recessive ends
with Klenow and blunt-end ligating the pRSVLacZcysC plasmid.
The cystatin C sequences of the transgene's mRNA should not be
translated, since the LacZ open reading frame contains a stop
codon. The cystatin C 3'- containing pRc/RSV plasmid
(pRSVcysC3') was obtained by digesting cystatin C cDNA with
Not I and Bgl II to yield a 340 base 3'half cystatin C
fragment.The 5' half of cystatin C was further digested with
Bst XI, which cleaves the fragment at position 229.The 3'-
halfcystatinCcDNAwasidentifiedandisolatedby80
fractionating on a low melting agarose gel (Gibco/BRL) and
removing the agarose by phenol/chloroform extractions and
precipitation with 95% ethanol.The 3'-half cystatin C was
cloned at the 3'-end Not I site into the single Not I site in
the polylinker region ofthe pRC/RSV plasmid,andthe
recessive ends where filled in with Elenow enzyme. The
plasmid was blunt-end ligated to make the pRSVcysC3' plasmid.
The direction of the 3' cystatin C insert was identified by
digesting with Pst I, which cleaves the cystatin C cDNA at
position 590, and a single site in the pRc/RSV plasmid in the
polylinker region upstream of the Not I site.
Transient transfection and histochemical assay:
Calcium phosphate-mediated transfection was carried out as
described (Helmrich et al., 1988).50 µg plasmid DNA in 50 mM
CaC12 (pH 7.2) was sheared with a 25 gauge needle and dropped
into a solution of 50 mM HEPES (n-2-hydroxyethylpiperazine-N-
2-ethane sulphonic acid) (pH 7.2), 0.25 M sodium chloride, 1.8
mM sodium phosphate (pH 7.2).Approximately 107 cells/ 75 cue
flask were transfected with the plasmid-containing solution.
After four hours, the cells were isolated and replated into 50
cm diameter dishes in triplicate, and the cells were grown for
an additional 4 hours.Staining of lacZ expressing cells was
done as described (Sanes et al., 1986).Cell monolayers were
gently rinsed three times with phosphate-buffered saline,
fixed with 1.9% formaldehyde/0.2% glutaraldehyde in phosphate-81
buffered saline, and stained with 0.5 mg/mlof 5-bromo-4-
chloro-3-indolyl-P-D-galactopyranoside (X-gal) in 44 mM HEPES
(pH7.2),3mM potassiumferrocyanide,3mM potassium
ferricyanide,15 mM sodium chloride, and 1.3 mMmagnesium
chloride in a final volume of 3 ml per 50 cmdiameter dish.82
RESULTS
mRNA stability regulation of cystatin C by TGF13:
The effect of TGF p on the stability of cystatin C mRNA was
investigated in SFME.SFME were first incubated with TGFp
for 24 hours to increase the basal level of message.Next,
the cells were incubated with a-amanitin (1 µg /ml) toblock
further transcription (Drew et al.,1989).The rate of
depletionoftheRNA wasdetermined by Northern blot
hybridization analysis of cells incubated with or without TGF
13(2 ng/m1) in the culture medium.The rate was compared to
the rate of depletion of(3 -actin and P8,an 8.5 Xb mRNA
specifically induced in SFME by TGF p (see Patrick Varga, PhD
dissertation,1992).Figure 4.1 represents the Northern
analysis of cystatin C and (3 -actin mRNA.P8 mRNA was also
measured in a repeat experiment (data not shown), and TGF 13
had no effect on it's stability.Although p actin mRNA shows
no significant decay with and without TGF13after 8 hour
transcription inhibition, there is an observable cystatin C
mRNA reduction after 8 hours transcriptioninhibition when
SFME are grown in the absence of TGFp.We have quantitated
the radioactivity (Figure 4.2), and we find a 40%decline in
cystatin C mRNA. In contrast, when TGF p is present after 8
hours there is no loss of cystatin C mRNA.83
Measurement of LacZ-cystatin C transgene expression:
We wished to determine if sequences in the cystatin C mRNA
could regulate a reporter gene by TGF p.We cloned the cDNA
in the sense and antisense direction downstream of thep-
galactosidase gene under the expression of the Rous sarcoma
virus LTR.The plasmid also contains the neomycin resistance
gene (neo), aminoglycoside 3' phosphotransferase,driven by
the SV40 late promoter (Fig. 4.3).We transfected SFNE grown
in the presence and absence of TGF p with 50 gg plasmid, and
isolated mRNA after 24 hours.Fig. 4.4 is a Northern blot
probed with cystatin C.The endogenous cystatin C mRNA is
induced by TGF 13, and can be detected after 8 hours exposure
to X-ray film.After 5 days exposure, an additional band of
approximately 4 Kb can be detected in the lanes containing RNA
from SFNE grown in the presence of TGF p.Initially, we
believed this message represented the lacZ-cystatin C hybrid.
However, probing with LacZ (Fig. 4.5) could not detect this 4
Kb message after 7 days exposure to X-ray film, although in a
100% LacZ-expression permanent SFNE clone, the message was
present.The neo message could be detected in all four
transient experiments,as well as the control,after an
overnight exposure (Fig.. 4.5).This suggests that neo mRNA
is more prevalent in transient transfection experiments than
the lacZ-cystatin C hybrid mRNA.
Also, we have cloned the 3' half of cystatin C into the84
RcRSV plasmid, which does not contain the LacZ gene, and we
haveobtained permanentSFME clonesresistanttoG418.
Probing for cystatin C in the total RNA from SFME grown with
and without TGF p cystatin C also revealed a 4 KB TGF (3-
regulated message,although the550 base3'cystatin C
transcript was not detected in all 4 clones (Fig. 4.6).
Since we could not measure the LacZcysC message by
Northern analysis, we decided to see if we could detect the
expressed protein by assaying for 0-galactosidase activity by
staining SFME.Table 4.1 contains data from several transient
transfection experiments designed to see if TGF p treated SFME
had higher P-galactosidase activity than SFME grown without
TGF p.In the first experiment, approximately 107 cells were
transfected with pRSVLacZcysC, after 4 hours the cells were
replated into 50 cm diameter dishes, and TGF p was added to
half the plates.After 4 hours, the cells were stained and
the number of blue cells was determined after a 24 hour
incubation.In both the serum free and TGF 0-added plates,
bluecellscouldbedetectedafter15minuteswith
approximately the same frequency and color intensity.After
3 hours, the staining appeared to be complete.The frequency
of transfection with and without TGF p was 272 blue cells/106
cells and 224 blue cells/106 cells, respectively.In the
second experiment, 107 cells were grown in the presence of TGF
p(2 ng/ml) for 24 hours.The cells were transfected with
plasmid, and after 4 hours replated into dishes with and85
without TGF p.After 4 hours, the cells were stained for p-
galactosidase activity, and counted after 24 hours.Again,
the number of blue stained cells was about the same with and
without TGF p, indicating that the cystatin C sequences did
not confer regulation by TGF p.As a control, SFME grown with
and without TGF p were transfected with pRSVlacZ.TGF p did
not affect the number of cells expressing P-galactosidase, as
was determined by staining and counting the number of blue
cells.
SFME are induced by hydrocortisone to express cystatin C:
After 48 hour of TGF [3 exposure, there was an approximate 2-
fold induction of cystatin C in SFME.We have tested other
growth factors and cytokines, including nerve growth factor,
platelet-derivedgrowthfactor,basicfibroblastgrowth
factor,(see Fig. 4.7), 7-interferon and T3.None induced
cystatin C in SFME.However, SFME cells grown serum-free in
the presence of hydrocortisone (10-7 M) for 24 hours had a
strong induction of cystatin C(Fig.4.7).GFAP is not
induced in SFME under serum-free conditions.We tested the
differentiation inhibitor, DIA, to see if cystatin C mRNA is
increased in SFME.DIA induced GFAP in SFME as determined by
Western blot analysis.After 48 hours treatment with DIA (10
ng/ml), we did not see an increase in cystatin C mRNA (Fig.
4.8).86
DISCUSSION
TGF p has multiple effects on the expression of genes
associated with the extracellular matrix; these include cell
attachment proteins,like collagen and fibronectin,their
receptors, and also several proteases and proteaseinhibitors.
The regulation of these genes is both transcriptionaland
post-transcriptional (Massague, 1990).In this report, we
present evidence that TGF 13 affects cystatin Cexpression by
stabilizing the message.After 8 hours of transcription
inhibition, there is a 40% decline in cystatin C mRNA when TGF
pis removed from the culture medium, but no decline in
message when it is present.Further analysis of the cystatin
C mRNA half-life may be made by extending theperiod of
transcription inhibition.The observation that (3 -actin mRNA
shows no significant decay after 8 hours of transcription
inhibitionisnotunusual;theaveragehalf-lifeof
cytoplasmic mRNA is 16 hours, and also SFME may not contain
high endogenous RNAse activity compared to some cells.
We report our attempts to regulate a reporter gene (LacZ)
by attaching cystatin C sequences to it's 3' end.It is known
(Ross and Robs, 1986) that mRNA decay is initiated at or near
the 3' terminus and proceeds 3' to 5'.Other experiments have
demonstrated the regulation of the stability of a reporter
gene's mRNA by attaching 3' regulatory elements fromvarious87
eukaryotic messages downstream of its sequences (Shaw and
Kamen, 1986; Sato et al., 1989).Cystatin C mRNA contains
several short, repeating sequences at it's 3' end that are in
close proximity to inverted repeat sequences.Therefore, we
wished to determine if these sequences confer TGF 0-regulated
stability.Although we were unable to regulate the LacZcysC
transgene expression, we believe that these sequences may
still have some function in cystatin C regulated expression;
they may operate with other sequences to control processing
and stability of the primary transcript. Previous experiments
report used P-galactosidase activity to measure regulated
expression of LacZ-containing transgenes (Norton and Coffin,
1985;Swergold,1990).Although in these experiments 0-
galactosidase activity was directly quantitated for enzymatic
activity,Swergold (199) compared the quantitation with the
number of cells stained by histochemical analysis of transient
transfection experiments, and found that these two analyses
corresponded.
We were unable to measure the LacZcysC hybrid mRNA by
Northern analysis although the neo mRNA was readily detected.
We do not know why the neomycin resistance gene mRNA is
detected so readily: it may be more stable than the LacZcysC
message.We have previously tested the ability of various
promoters to direct LacZ expression by transient transfection
of SFME, and we do not find significant differences in the
strengths of the two promoters, SV40 and RSV LTR.We find88
that many of our pRSVLacZ-containing and pRSVcysC3 '-containing
permanent SFME clones are G418 resistant, but do not express
thegenesdrivenbyRSVLTRbasedonNorthernand
histochemical analysis.It is reported that the neo gene
contains sequences that act as silencers of transcription
(Artelt et al., 1991).Thus, removal of the neo gene before
transfection may enhance the expression of RSV-driven genes.
An approximately4Kb message wasdetected after
extended exposures of Northern blots containing RNA from
transiently transfected SFME and RSVcys3'-containing SFME
clones.This message is induced by TGF p, and is the correct
sizeofthepredictedcystatinCprimarytranscript
(Abrahamson et al., 1989).We can detect this 4 Kb message in
untransfected cells.Although they are inherently unstable,
unprocessedmessageshavebeendetectedinNorthern
experiments (Silver et al., 1990; Ferrari et al., 1992). If
the4Kb message is indeed the primary transcript,this
suggests that cystatin C is also regulated in the nucleus.
The promoter region of human cystatin C has been described
(Abrahamson et al., 1989), and it has house-keeping features.
It is known that the transcription rates of constitutive genes
do not correlate with the intracellular levels of their
respective mRNAs (Cabrera et al., 1984).Thus, it may be that
increased levels of the primary transcript in the presence of
TGF f3 is due to a post-transcriptional event.
Cystatin C is markedly induced by hydrocortisone in SFME89
although GFAP is not induced under serum-free conditions.
Steroid compounds often regulate genes transcriptionally, but
therearereportsthat theyalsooperatepost-
transcriptionally.For example, estrogen and it's receptor
dramatically stabilizes vitellogenin mRNA (Brock and Shapiro,
1983).Also, in rat fibroblasts dexamethasone affects the
stability of the procollagen mRNA (Raghow et al.,1986).
FurtheranalysisoftheregulationofcystatinCby
hydrocortisone will need to be made to begin to discern it's
effects on gene expression in SFME.90
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Fig. 4.3:Diagram of the pRSVLacZcysC plasmid.The LacZcysC
transgene is driven by the Rous sarcoma virus long terminal
repeat.The size of the Vgalactosidase gene (LacZ) is 3.5
Kbp.Cystatin C cDNA is 660 bp. Also contained in the
plasmid is the neomycin resistance gene under the direction of
the SV40 promoter.The neomycin resistance gene (neo)is
approximately 1.1 Kbp and is polyadenylated by the SV40 late
polyadenylation sequences.18S
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Fig. 4.4: Northern blot analysis of the transient transfection
of SFME with pRSVLacZcysC probed for cystatin C.Cells were
transfected with plasmid, then were grown for 24 hours in the
presence and absence of TGF p.RNA was isolated, DNAses and
probed with 32P-radiolabeled cystatin C cDNA. (A) RSVLacZ 100%
stablyintegratedclone; (B)transiently transfect with
RSVLacZcysC(Sense), w/o TGF p, 24h; (C) transiently transfect
with RSVlacZcysC(sense), with TGF 13,24h;(D)transiently
transfect with RSVlacZcysC(antisense), w/o TGF p,24h;(E)
transiently transfect with RSVlacZcysC(antisense), with TGF p,
24h.LacZ
ABCDE
neo
18S
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Fig. 4.5: Northern blot analysis of the transient transfection
of SFME with pRSVLacZcysC probed for lacZ and neo.Cells were
transfected with plasmid, then were grown for 24 hours in the
presence and absence of TGF p. (A)RSVLacZ 100% stably
integrated clone; (B) transiently transfect with
RSVLacZcysC(Sense), w/o TGF p, 24h; (C) transiently transfect
with RSVlacZcysC(sense), with TGF 13,24h;(D)transiently
transfect with RSVlacZcysC(antisense), w/o TGF p,24h;(E)
transiently transfect with RSVlacZcysC(antisense), with TGF p,
24h.Probed with 32P-radiolabeled Vgalactosidase gene (lacZ)
and neomycin resistance gene (neo) cDNA.+-+-+-+ AASS
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Fig. 4.6:Detection of 4 Kb transcript in RSVcysC3' SFME
clones treated with TGF [3.Total RNA was isolated from four
independent,G418 resistant SFME clones transfected with
pRSVcysC3'.20 lig RNA was isolated for Northern analysis of
clones containing the 3' half of cystatin C in the antisense
direction (A) and sense (S) direction downstream of the Rous
sarcoma virus long terminal repeat.Each of the four clones
were grown in the presence (+) and absence (-) of TGF p(2
ng/ml, 48 h).ABCD
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Fig. 4.7: Northern blot analysis of cystatin C induction in
SFME by hydrocortisone. SFME were grown serum-free and
treated for 24 hours with (A) hydrocortisone(10-7 M),(B)
serum-free,(C) with TGF p (2 ng/ml), 24 hours,(D) with TGF
p(2 ng/ml, 48 hours).A B C
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Fig. 4.8:DIA does not induce cystatin C in SFME.SFME were
grown in the presence of differentiation inhibitory activity
(DIA), 10 ng/ml for 48 hours.RNA was isolated and probed for
cystatin C by Northern blot analysis.A: 20 lig total RNA from
SFME treated with DIA (10 ng/ml, 48 h). B: 201.tg total RNA
from SFME grown under serum-free conditions. C: 20 µg total
RNA from SFME treated with TGF 13(2 ng/ml, 48 h).99
Table 4.1:Transient transfection of SFME with pRSVLacZcysC
in the presence and absence of TGFp. Measure of 13-
galactosidase activity in SFME. After transfection, the
cells were incubated for 4 h with and without TGF p before
staining and counting for blue cells.
Exp. TGF 13 SF
design
0 blue cells/106 cells)
1.pRSVLacZ 1066/0.25x16 880/0.25x16
control
2.transfect cells 224(1). 272(1)
with pRSVLacZcysC
w/o TGF p
3.transfect TGF p- 486(3) 319(3)
treated (24 h) cells
with pRSVLacZcysC
numbers in parentheses indicate the number of 50cm plates
counted.Each dish was counted if there were less than 200
blue cells/dish, approximately 200 blue cells were counted and
the number of blue cells was extrapolated from the area of the
dish counted.100
CHAPTER V
CONCLUSION and FUTURE PERSPECTIVES
The biologist may find interesting the research in this
thesis about the species distribution of S-protein. We detect
what appears to be a single copy gene in the seven mammals we
examined.It maybe interesting to more carefully analyze the
conserved regions of this multidomain protein in mammals.
Whether we will find a related S-protein gene in a more
divergent species may depend on if there are fundamental and
essential regions found in this protein. The gene for
cystatin is ancient;it is over 1 million years old.A
cystatin-relatedgenehasbeendetectedinDrosophila
(Delbridge and Kelly, 1990).The gene exists in chicken, and
the corresponding amino acid sequence is over 50% homologous
with human cystatin C (Rawlings and Barrett, 1990).It may be
interesting to see if cystatin is present in a genetically
definable system, such as yeast, in order to characterize it's
cellular functions.
What may interest the cell biologist, is the research
that examines the patterns of expression of S-protein and
cystatinC. S-protein,aserumglycoprotein,isa
multifunctional protein that is expressed at high levels by101
the liver, and also we detect its mRNA in the brain.Cystatin
C, also found at high concentrations in serum, is expressed at
varying levels by many different tissues, and it's mRNA is
most prevalent in the heart, lung and brain.Both genes have
been associated with amyloid deposits in the brain (Grubb et
al., 1984; Akiyama et al., 1991).Both have been found to be
regulated in certain cell lines by transforming growth factor
3.We would like to know more about the distribution of these
two genesin the brain and their biologicalfunctions.
Although our proastroblast cell line, SFME, can be strongly
induced to express cystatin C, we are unable to detect S-
protein produced by these brain cells.There are several
filialand neuronal celllinesavailable to examine the
expression and growth factor-regulation of these two genes.
Continuing in-situ hybridization and immunochemical assay
studies of various brain sections from young, aged, diseased
and injured mouse brains may outline their location and give
some hints about their possible functional rolesin the
central nervous system.There is evidence that cystatin C has
a developmentally-regulated expression in the brain.Several
proteases and protease inhibitors are known to regulate
neurite outgrowth,and it may be that cystatin has some
involvementinbuildingneuralnetworksduringbrain
development, and maintaining them throughout life. Associated
with this, is S-protein's ability to bind glia- derived nexins,
which are known neurite outgrowth promoting agents. Cystatins102
have been purified from bovine brain that inhibit substance P
degradation by cysteine proteases (Aghajanyan et al., 1988).
It may be that cystatin C plays a role in the processing and
turnover of various neurotransmitters and neuropeptides during
their secretion or in the extracellular space.Proenkephalin
is known to be processed by a cysteine protease present in
secretory vesicles. It has been determined that mature
astrocytes secrete unprocessed proenkephalin, and it may be
interesting to see if proastroblasts, like SFME, can process
the neuropeptide.When SFME are induced to differentiate in
SFME by TGF 0, cystatin C may inhibit proenkephalin processing
by inhibiting this cysteine protease.
As a biochemist, I am particularly interested in gene
regulation of cystatin C in SFME.Cystatin C is markedly
induced by TGF p in SFME, and the mRNA is increased after four
hours of exposure to the growth factor.It is a secreted
protein, and the release into the culture medium parallels the
mRNA increase.We have tested other cell lines for TGF f3-
regulated expression, and have found them not to be regulated
by TGF p for the expression of cystatin C.I present evidence
in this thesis that TGF p stabilizes cystatin C mRNA, and
although I was unable to discern the particular regions of the
cystatin message involved in regulating the stability, the
results are in agreement with the many findings that TGF p
affectscertaingenes'post-transcriptionally. The
observation that cystatin C can be induced by TGF p when103
protein synthesis is inhibited is a clear suggestion that
prior gene expression by immediate early genes,such as
transcription factors, are not necessary.In contrast, GFAP
induction by TGF p is abolished by cycloheximide treatment.
ManyreportsdescribeGFAP'stranscriptionalregulation
(Sarid, 1991; Mucke et al., 1991), and our finding that prior
protein synthesis is necessary for this gene's induction by
TGF p is evidence that initial induction of gene activators is
needed to direct GFAP gene transcription.
We find a 4 Kb message is induced by TGF that is
detected by cystatin C probe.I believe this message is the
primary cystatin C transcript, which suggests that there is
regulation of the gene in the nucleus.It is not as likely
that the message is instead a related gene that shares some
homology with cystatin C; the cystatin gene family has been
extensively investigated, and there are no such genes with
mRNA of this size.To establish that itis unprocessed
cystatin C message, we will need to clone the cystatin C gene
and obtain intron sequences as probes.We will need to
isolate nuclear RNA to make sure that the transcript is
located in the nucleus, since it is possible that unprocessed
message may leak into the cytosol, and be regulated by TGF 13
in this location.If it is indeed nuclear-derived, we may
also want to determine the control point(s) of cystatin C gene
expression in the nucleus, and the factors involved in this
regulation.The signal transduction pathways involved in the104
regulation of cystatin C are also interesting. Protein kinase
C is probably not involved, since Northern blot analysis of
TPA-treated SFME shows no increased cystatin C mRNA levels.
TPA induces a morphology in SFME similar to TGF 0.Whether
GFAP is induced by TPA has not been determined.105
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APPENDIX
Cystatin C release into SFME conditioned medium
INTRODUCTION
We have detected a message that encodes thecysteine
protease inhibitor, cystatin C, that is stronglyinduced by
TGF 1in serum free mouse embryo cells.Cystatin C is a
secreted protein and an inhibitor of the cathepsins 8, H,and
L, as well as the cysteine protease,papain.We wished to
determine the time course of cystatin C's release into the
conditioned medium of SFME treated with TGF fby measuring
it's ability to inhibit papain protease activity.118
METHODS
Cystatin C was quantitated as described (Lah et al.,
1989) using chicken egg white cystatin (Sigma) as astandard.
SFME were grown in the presence of TGFp (10 ng/ml) for 0, 3,
8, 18, 28, 48, and 72 h.The conditioned medium was harvested
and was immediately freezed at -88 °C until it was usedfor the
experiments.Commercial papain (Type III) was purchased from
Sigma.A stopped assay was performed tofluorimetrically
measure the inhibition of papaincleavage of the substrate Z-
Phe-Arg-Methoxy-P-naphthylamide (Enzyme System Products) .The
enzyme (final concentration, 1.0 nM) waspreincubated for 10
min. at 25 °C with the appropriate dilution of thestandard
inhibitor, chicken cystatin (final concentrations 0,0.15,
0.30, 0.60, 1.0, and 3.0 nM) in the presence of 10 mM DTT,0.2
M citrate buffer (pH 6.2), 1.0 mM EDTA, 2.0%F12/DMEM (final
volume, 80041).Similarly, the TGF (3- treated SFME conditioned
medium (2.0%)for each timepoint was incubated with the
enzyme.After 10 min. at 25°C, the substrate was added (final
concentration,0.5 mM),and the reaction was allowed to
proceed for 15 min. at 25°C.The reaction was stopped by
addition of 400 41 of 1 N HC1.The increase in fluorescence
was measured at an excitationwavelength of292 nm and
emission wavelength of 410 nm.Buffer blanks were prepared by
adding buffer instead of enzyme and inhibitor.119
RESULTS
A stopped assay was performed to determine the cysteine
protease inhibitory activity in the culture media of TGF13-
treated SFME.It was assumed that papain-inhibition was
completely due to the release of cystatin C into the media,
since cystatin C was determined to be induced by TGF 13 by
Northern blot analysis.A standard curve was made using
chicken cystatin, and it was assumed that the inhibitory
activities of cystatin C and chicken cystatin are equivalent
under the experimental conditions. After 15 minutes of enzyme
incubation with the substrate, the reaction was terminated and
papainactivitywasmeasured. Chickencystatinat
concentrations ranging from 0to 3.0 nM linearly reduced
papain'scleavageofthesubstratefrom0to50%,as
determined byspectrofluorimetricanalysis. Athigher
concentrations of chicken cystatin the standard curve was non-
linear.Using 2.0% SFME culture media, these samples gave
values that fit into the linear portion of the standard curve.
There appears to be a linear increase with time of cysteine
protease inhibitory activity released into the TGF 0-treated
SFME conditioned medium.After 48 hours of TGF p treatment,
the culture medium of SFME had approximately 34 nM amounts of
cystatin C (Fig. 3.8).120
DISCUSSION
After 48 hours of TGF p exposure, cystatin C mRNA is
increased 20-fold in SFME.We also see an increase in the
cysteine protease inhibitory activity present in SFME culture
medium.Our initial attempts to quantitate the activity may
be further improved by several means:The concentration of
papain was used according to the assigned values of the
manufacturer. We may increase the purity of the enzyme by gel
filtration, and a microscale titration analysis of the active
site can be gotten using synthetic irreversible inhibitors,
like a-bromo-4-hydroxy-3-nitroacetophenone. Similarly, we may
increase the purity of the chicken cystatin standard by gel
filtration or affinity chromatography, and determine it's
molar concentration and inhibitory activity once the precise
concentration of papain is known.We may want to examine the
relative stability of cystatin C released into the culture
medium;this may bereduced by secreted proteases,or
proteases released into the medium from degenerating cells.
The effects of storage on the protease inhibitory activity of
the conditioned medium may be examined by measuring it's
activity before and after freezing the medium. We may want to
repeat the experiment and isolate media from TGF (3- treated
SFMEatmanytimepointsintriplicate,sincethe
concentration values we have assigned are from a single data121
point at all the timepoints we previously examined. A
determination of the inhibition constant of cystatin C in SFME
media may be made by a continuous assay of papain activity to
measure the rate constants in the absence and presence of
inhibitor.A comparison with the known values for papain and
cystatin C activity constants should be made. Finally,
cystatin C can be purified from the culture media by standard
methods (Lah et al., 1989) to demonstrate that TGFinduction
of cystatin C involves the secretion of the final product.